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ABSTRACT 
 
 
 
 
 
Although several studies demonstrate that inflammation contributes to 
neurodegenerative and psychiatric disorders, the physiological functions of immune 
molecules in synapse formation and functionality are not completely known. Interleukin-1β 
(IL-1β) has been described as one of the main pro-inflammatory cytokines involved in 
several neurological disorders. IL-1β is produced by many types of cells, including immune 
cells in the periphery, as well as glia and neurons within the brain [Dinarello CA, 1996]. The 
ability of IL-1β to influence cellular functions depends on the expression of the appropriate 
receptor and the activation of specific intracellular signaling pathways. Two receptors for IL-
1β have been identified, but only the type 1 receptor (IL-1R1) is signal transducing [Sims 
JE et al., 1993]. IL-1R1 is expressed on central nervous system (CNS) glia (astrocytes and 
microglia), particularly after injury [Friedman WJ, 2001], and also on specific populations of 
CNS neurons, including hippocampal pyramidal neurons [Yabuuchi K et al., 1994; Ericsson 
A et al., 1995; Friedman WJ, 2001]. IL-1β elicits distinct functional effects in these CNS cell 
types, regulating the production of inflammatory cytokines in glia and influencing synaptic 
function of hippocampal neurons, affecting long-term potentiation (LTP) [Katsuki H et al., 
1990; Bellinger FP et al., 1993; Murray CA and Lynch MA, 1998; Kelly A et al., 2001]. 
Previous studies reported that impaired Interleukin-1 signalling is associated with deficits in 
hippocampal memory processes and neural plasticity [Avital A et al., 2003] and that IL-1R 
is essential for the activation of microglia and the induction of proinflammatory mediators in 
response to brain injury [Basu A et al., 2002].  
Despite the well-established role of this cytokine in different brain diseases, its 
putative physiological function during normal brain development is not completely known. 
The aim of this study is to clarify if, and how, Interleukin-1 signalling participates in the 
maintainance of synapse homeostasis in the CNS. In order to study how endogenous IL-
1β signaling may alter normal brain development and functionality, we took advantage of 
an IL-1 type 1 receptor (IL-1R1) knock-out mouse model, where the IL-1 signaling is 
genetically blocked.  
Our results show that lack of IL-1R affects excitatory inputs in vivo, leading to a 
significant increase in the expression of excitatory synaptic markers in both cortex and 
hippocampus. In line with this evidence, Golgi-cox staining of fixed brain slices revealed a 
significantly higher spine density in CA1 pyramidal neurons of IL-1R-/- hippocampi. 
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Consistently, electrophysiological recordings from hippocampal acute slices demonstrated 
enhanced frequency and amplitude of miniature excitatory postsynaptic currents in IL-1R-/- 
mice, confirming the functional potentiation of the excitatory signalling in the hippocampus 
of knock-out mice. We also observed a transiently increased number of parvalbumin-
positive GABAergic interneurons in the hippocampal CA1 region of P30 IL-1R-deficient 
mice (although, this increased number is completely rescued in older mice), suggesting a 
possible role of IL-1 signalling in the control of the GABAergic system during early stages 
in life. These data demonstrate a key role of the IL-1 receptor in controlling excitatory and 
inhibitory network refinement and strengthening during brain development. However, this 
process was not observed in primary culture of hippocampal neurons established from IL-
1R-/- mice, thus suggesting a non-cell-autonomous effect. In line with this observation, we 
observed a transient increase in microglia number in IL-1R-/- mice during the first weeks of 
postnatal life (a critical time point for synapse maturation and elimination), although 
completely recovered in older mice. Moreover, using mixed co-cultures, we found that IL-
1R-/- microglia cells were less effective in promoting synaptic elimination when compared to 
WT microglia cells.  
In conclusion, IL-1R signaling seems to play a key role in modulating glutamatergic 
and GABAergic synapses and its absence leads to a general and long-lasting potentiation 
of excitatory inputs. Since microglia contribute to synaptic pruning and network refinement 
in the first postnatal weeks, the alteration in microglia-mediated synapse pruning in IL-1R-/- 
mice may be involved in this process, eventually leading to short-term effects on postnatal 
synaptic maturation and long-term effects on adult brain networks. 
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INTRODUCTION 
 
 
 
 
 
 The Communication Between the Immune and Nervous System 
 
The inflammatory response is a crucial aspect of the tissues’ responses to deleterious 
injuries or microbial infections and has the physiological purpose of restoring tissue 
homeostasis. Inflammation can either resolve or progresses to acute or chronic. Chronic 
inflammation is not only typical of classical inflammatory diseases but also an underlying 
feature of a variety of human conditions not previously thought to have an inflammatory 
component, including Alzheimer’s disease, atherosclerosis, cardiovascular disease, and 
cancer. Inflammation involves a sequence of organized, dynamic responses including both 
vascular and cellular events with specific humoral secretions. The occurrence of vascular 
events is rapid as they appear in a few minutes following tissue injury or microbial infection 
in the presence of other inflammatory stimuli, and they eventually lead to vascular dilation, 
enhanced permeability of capillaries, increased blood flow and recruitment of inflammatory 
mediators and leukocytes (such as macrophages, neutrophils, monocytes and 
lymphocytes) from the circulatory system at the inflamed site, producing interstitial edema. 
In particular, polymorphonuclear neutrophils are among the first leukocyte responders to 
accumulate in the inflamed site. These cells are crucial as the first line of defense of the 
innate immune system because of their phagocytotic and microbicidal functions. Next, 
mononuclear cells (monocytes and macrophages) enter the inflammatory site and clear 
cellular debris and apoptotic polymorphonuclear neutrophils by phagocytosis without 
prolonging inflammation. Leukocytes also release specialized substances including 
vasoactive amines and peptides, eicosanoids, proinflammatory cytokines and acute-phase 
proteins, which mediate the inflammatory process by preventing further tissue damage and 
ultimately resulting in healing and restoration of tissue function. Among these pro-
inflammatory mediators, pro-inflammatory cytokines (such as interleukin-1 beta, interleukin-
6, tumor necrosis factor alpha) specifically control the initiation of inflammation and its 
maintenance and regulate its amplitude and the duration of the response. Failure to resolve 
the inflammatory response, or continuous activation of the responses, become harmful to 
the tissue and consequently develop into the chronic lesions that are associated with 
inflammatory diseases [Freire MO and Van Dyke TE, 2013; Sugimoto M et al., 2016; 
Abdulkhaleq LA et al., 2018]. 
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The communication between the cells of the immune system is mediated by small 
soluble proteins called cytokines. These proteins have pleiotropic local (paracrine and 
autocrine) and systemic (endocrine) actions, and they are predominantly produced in 
substantial amount in response to inflammatory conditions. Inflammation is a non-specific 
systemic response designed to maintain the integrity of the organism (either localized or 
diffuse). Once inflammation is triggered, a reciprocal communication between the central 
nervous system (CNS) and the periphery is required for mounting an efficient and effective 
defensive response. Thus, systemic inflammation has a neurological component, and the 
activation of peripheral inflammatory responses is required for neuroinflammation to 
become effective [for review see Dinarello CA et al., 1996 and Johnson RW et al., 2002]. 
During inflammation, cytokine actions largely drive, in any organ, both destructive and 
reparatory processes. For many years, the brain has been considered immune-privileged 
because of its apparent inability to initiate a classical response to exogenous antigens and 
the presence of the highly selective blood-brain barrier (BBB). However, it is now well known 
and largely accepted that the brain can mount a response to injury which is carried out by 
invading leukocytes and other brain-specific cells, using the same soluble mediators as the 
systemic immune response. This response is known as neuroinflammation. Cytokines also 
mediate signalling to the brain when there is the need for a systemic response to protect 
the organism. First discovered due to their massively increased release in pathological 
conditions, they were also shown to have positive effects at physiological concentrations on 
neural activity and were suggested to be essential during this development of the nervous 
system [Deverman BE and Patterson PH, 2009; Stolp HB, 2013; Mousa A and Bakhiet M, 
2013; Ratnayake U et al., 2013]. Cytokine effects were found to differ depending on their 
levels of expression, the target organ, and, very importantly, the developmental window. 
Interleukin-1 (IL-1) is one of the most representative cytokines with pleiotropic effects, as it 
appears to affect almost every cell type in the mammalian organism. In the literature, there 
is now a great deal of evidence providing irrefutable support for its role in inflammation-
driven pathologies, although this cytokine also plays central roles in various physiological 
processes [Basu A et al., 2004; Fogal B and Hewett SJ, 2008; Shaftel SS et al., 2008; Mills 
KH and Dunne A, 2009; Gabay C et al., 2010; Dinarello CA et al., 2012; Pozzi D et al., 
2018; Mendiola AS and Cardona AE, 2018].  
 
 
1.1 The IL-1 Family of Cytokines and The Innate Immune System 
 
Initially considered the prototypical proinflammatory cytokine, IL-1 has several other 
effects that are far from promoting inflammation. Some of its pleiotropic central actions 
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comprise fever [Dinarello and Wolf, 1982], appetite control [Mrosovsky et al., 1989], bone 
metabolism [Bajayo et al., 2005], central pain modulation [Wolf et al., 2003], stress response 
by modulating hypothalamic-pituitary-adrenal (HPA) axis function [Goshen et al., 2003] and 
memory modulation [Schneider et al., 1998].  
More than 95% of living organisms use innate immunity for survival whereas less than 5% 
depend on T- and B-cell functions. More than any other cytokine family, the IL-1 family is 
primarily associated with innate immune responses, which manifest by inflammatory 
processes that can be beneficial when functioning as a mechanism of host defence, but 
also detrimental to survival when uncontrolled.  
The IL-1 family of cytokines and receptors is considered to be unique in immunology 
because of the similar functions shared by the IL-1 and Toll-like receptor (TLR) families. In 
fact, each member of the IL-1 receptor and TLR family contains the cytoplasmic Toll-IL-1-
Receptor (TIR) domain. However, while TLRs trigger inflammation by bacteria, microbial 
products, viruses, nucleic acids, and damage-associated molecular patterns (DAMPs), 
innate inflammation via IL-1 family of receptors is triggered by IL-1 family cytokine members. 
Although the inflammatory properties of the IL-1 family members can also play a role in 
acquired immunity, they mainly control innate immunity. 
What characterizes innate immunity is the lack of specificity towards a certain antigen. 
Indeed, the numerous biological properties of the IL-1 family are nonspecific. IL-1 family 
non-specifically augment antigen recognition and activate lymphocyte function. IL-1β is the 
most studied member of the IL-1 family due to its role in mediating autoinflammatory 
diseases (see Table 2) [Dinarello CA, 2018]. 
 
 
1.1.1 IL-1 And IL-1R Family Members 
 
Although originally the IL-1 family comprised only IL-1α and IL-1β, it has expanded 
considerably in the last decades. The IL-1 family of ligands now includes 7 molecules with 
agonist activity (IL-1α, IL-1β, IL-18, IL-33, IL-36α, β, and γ), three receptor antagonists (IL-
1Ra, IL-36Ra and IL-38), and an anti-inflammatory cytokine (IL-37) (Table 1). 
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Table 1 IL-1 family members 
 
(Adapted from: Carta S et al., Front Immunol 2013) 
 
 
The IL-1 family can be divided into subfamilies according to the length of the precursor (the 
inactive form of the protein) and the length of the propiece (the portion that originates the 
active form of a protein after cleavage of the precursor), as well as to the primary ligand 
binding receptor (Figure 1). 
Except for the IL-1 receptor antagonist (IL-1Ra), all other members lack a signal peptide 
and are primarily intracellular precursors. The IL-1 subfamily is comprised of IL-1α, IL-1β 
and IL-33. This subfamily has the longest proteins with the longest propieces. While the 
propiece of IL-1β needs to be cleaved intracellularly by caspase-1 to be secreted as a 
mature cytokine, in the case of the IL-1α precursor, the cleavage is performed by either the 
membrane protease calpain or the extracellular neutrophil proteases. Extracellular 
neutrophil proteases also account for the cleavage of the propiece of IL-33. IL-18 and IL-37 
are members of the IL-18 subfamily. IL-18 requires the cleavage of its propiece by caspase-
1 in order to become active. It is unclear how the propiece of IL-37 is removed. The IL-36 
subfamily, which has the shortest propiece, comprises of IL-36α, β and γ, as well as IL-
36Ra. In addition, because of its biding to the IL-36R, IL-38 likely belongs to this family 
[Dinarello CA, 2013, 2018]. A–X–D is a consensus sequence found in all members of the 
IL-1 family, where A is an aliphatic amino acid such as isoleucine, methionine or leucine, X 
is any amino acid and D is aspartic acid. The A–X–D motif is conserved in the IL-1 family 
where it plays a pivotal role in three-dimensional structure of the active cytokine. The actual 
N-terminus is often located 9 amino acids before the A–X–D site. By eliminating the amino 
acids before the N-terminus, the first β-sheet structure common to all members of the IL-1 
family can form [Carta S et al., 2013; Garlanda C et al., 2013; Boraschi D and Tagliabue A, 
2013; Dinarello CA, 2013; Palomo J et al., 2015; Boraschi D et al., 2018]. 
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Figure 1. Organization of the IL-1 subfamilies. The total amino acid number of 
the dominant precursor isoform is indicated for each member of the IL-1 family of 
ligands. The vertical line for each member indicates the likely propiece-mature 
boundary derived from either a caspase-1 cleavage site or nine amino acids 
upstream from the consensus sequence A–X–D as the likely N-terminus. A red 
circle represents the members with primary pro-inflammatory properties, whereas 
a green circle represents cytokines that are anti-inflammatory. Because IL-1Ra 
has a signal peptide and is readily secreted, there is no A-X-D site. (Adapted 
from: Charles Dinarello, Elsevier 2013) 
 
 
There are several members of the IL-1 family of receptors. A simplified nomenclature for IL-
1R members is proposed here: IL-1R1 (IL-1RI), IL-1R2 (IL-1RII), IL-1R3 (IL-1RAcP), IL-1R4 
(ST2), IL-1R5 (IL-18Ra), IL-1R6 (IL-1Rrp2, IL-36R), IL-1R7 (IL-18Rb), IL-1R8 (TIR8, also 
known as SIGIRR), IL-1R9 (TIGIRR-2), IL-1R10 (TIGIRR-1) (Figure 2). 
The receptor chains are generally characterized by an extracellular portion consisting of 
three immunoglobulin (Ig)-like domains. Notable exceptions are the IL-18 binding protein 
(IL-18BP) and TIR8, which have a single Ig domain. The intracellular domains of the IL-1Rs 
share some homology with those of Toll-like receptors (TLR), known as Toll-like/IL-1R (TIR) 
domains and are essential for starting the signalling recruiting intracellular adaptors. IL-1R2 
is the only IL-1R family member lacking a TIR domain.  
IL-1R1 binds IL-1α, IL-1β, and IL-1Ra. IL-1R3 (formerly IL-1R accessory protein) is the 
coreceptor for forming a trimeric signalling complex with IL-1α or IL-1β. In the resting state, 
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IL-1R1 and IL-1R3 are present on the cell membrane. Once IL-1 (either IL-1α or IL-1β) binds 
to IL-1R1, a structural change occurs that allows IL-1R3 to bind to IL-1R1. There is no direct 
contact of the ligand(s) to the IL-1R3 coreceptor. The trimeric complex allows for the 
proximity of the TIR domains of each receptor chain with subsequent recruitment of 
intracellular components that triggers a cascade of kinases that produce a strong pro-
inflammatory signal leading to the activation of NF-κB. IL-1R3 also exists as a soluble 
receptor form. A common mechanism for forming soluble receptors is the cleavage from the 
cell surface as a secreted potein; however, the soluble form of IL-1R3 is also produced by 
the liver. IL-1R2, a decoy receptor for IL-1β, lacks a cytoplasmic domain, does not signal, 
but rather sequesters IL-1β. IL-1R2 exists as an integral membrane protein but also as a 
soluble form. Although soluble IL-1R2 binds IL-1β in the extracellular space, neutralization 
of IL-1β activity is greatly enhanced by the formation of a complex with soluble IL-1R3. IL-
1R2 associates intracellularly with the IL-1α precursor and prevents the release and 
subsequent extracellular processing of the precursor by calpain. IL-1R3 is also the 
coreceptor for IL-33, IL-36α, IL-36β, or IL-36γ. The ligand binding receptor for IL-33 is IL-
1R4 (formerly, ST2). The IL-36 receptor (IL-1R6) binds IL-36α, IL-36β, or IL-36γ but also 
IL-38. Importantly, the IL-1 family of receptors also contains anti-inflammatory receptors. 
These are IL-1R8 (formerly SIGIRR, TIR8), IL-1R9 (formerly TIGIRR-2, IL-1RAPL1), and 
IL-1R10 (formerly TIGIRR-1). It has been shown that mice deficient in IL-1R8 develop 
spontaneous inflammation and, when challenged with inflammatory agents, these mice 
display more severe disease. The IL-18 binding protein (IL-18BP) is not a classic receptor 
because it is a secreted protein; nevertheless, IL-18BP contains a single IgG domain similar 
to the extracellular IgG-like domains of the IL-18Rα but no cytoplasmic domain. The IL-
18BP functions similarly to other soluble receptors in the IL-1 receptor family, binding and 
neutralizing the cognate ligand [Carta S et al., 2013; Garlanda C et al., 2013; Boraschi D 
and Tagliabue A, 2013; Dinarello CA, 2013; Palomo J et al., 2015; Boraschi D et al., 2018]. 
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Figure 2. Ligands and Receptors in the IL-1 Family. A schematic 
representation of ligands and receptor chains in the IL-1 family. The minus sign 
indicates inhibition. (Adapted from: Cecilia Garlanda et al., Immunity Review 
2013) 
 
 
1.1.2 IL-1 Pathway 
 
The main function of IL-1–type cytokines is to control proinflammatory reactions in 
response to tissue injury by pathogen-associated molecular patterns (PAMPs, such as 
bacterial or viral products) or damage- or danger-associated molecular patterns released 
from damaged cells (DAMPs, such as uric acid crystals or adenosine 5´-triphosphate) 
[Gaestel M et al., 2009; Dinarello CA, 2009; Martinon F et al., 2009]. 
While IL-1α is primarily membrane anchored and acts through autocrine or juxtracrine 
mechanisms [Keller M et al., 2008], IL-1β is secreted by an unconventional protein secretion 
pathway and can signal in a paracrine manner or systemically [Dinarello CA, 2005]. IL-1α 
and IL-1β rapidly induce mRNA expression of hundreds of genes in several different cell 
types, such as monocytes or macrophages [Allantaz F et al., 2007; Jura J et al., 2008], 
epithelial cells [Hoffmann E et al., 2005], endothelial cells [Bandman O et al., 2002], 
chondrocytes [Vincenti MP and Brinckerhoff CE, 2001; Joos H et al., 2009] and fibroblasts 
[Holzberg D et al., 2003; Jeong JG et al., 2004]. In parallel, they also induce expression of 
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their own genes, allowing a positive-feedback loop that amplifies the IL-1 response in an 
autocrine or paracrine manner [Dinarello CA et al., 1987; Granowitz EV et al., 1992; 
Dinarello CA, 1996; Hoffmann E et al., 2005; Gaestel M et al., 2009]. Stimulation of 
transcription occurs within 30 min of exposure to IL-1α or IL-1β and can be sustained for 
many hours [Krause A et al., 1998; Hoffmann E et al., 2005; Wolter S et al., 2008]. The 
gene-regulatory actions of IL-1 are transmitted by a conserved signalling system that relies 
on the rapid, transient, and reversible assembly of multiprotein complexes that comprise 
both non-enzymatic adaptor proteins and enzymes [Weber A et al., 2010]. 
IL-1α and IL-1β independently bind the type I IL-1 receptor (IL-1R1), which is ubiquitously 
expressed. A third specific ligand, the IL-1 receptor antagonist (IL-1RA), binds the IL-1R1 
with similar specificity and affinity but does not activate the receptor with consequent 
downstream signalling [Eisenberg SP et al., 1990; Vigers GP et al., 1997; Schreuder H et 
al., 1997; Dunn E et al., 2001]. The IL-1 receptor accessory protein (IL-1RAcP) serves as a 
co-receptor that is required for signal transduction of IL-1/IL-1R1 complexes, and this co-
receptor is also necessary for activation of IL-1R1 by other IL-1 family members, in particular 
IL-18 and IL-33 [Wesche H et al., 1997; Dunn E et al., 2001; Arend WP et al., 2008].  
The initial step in IL-1 signal transduction is a ligand-induced conformational change in the 
first extracellular domain of the IL-1R1 that facilitates recruitment of IL-1RAcP [Casadio R 
et al., 2001]. Through the conserved cytosolic regions TIR domains [Radons J et al., 2003], 
the trimeric complex rapidly assembles two intracellular signalling proteins: the myeloid 
differentiation primary response gene 88 (MYD88) and the interleukin-1 receptor–activated 
protein kinase (IRAK) 4 [Li S et al., 2002; Brikos C et al., 2007; De Nardo D et al., 2018]. 
IL-1, IL-1RI, IL-RAcP, MYD88, and IRAK4 form a stable IL-1–induced first signalling module 
[Brikos C et al., 2007]. This occurs in parallel to the (auto)phosphorylation of IRAK4, which 
subsequently phosphorylates IRAK1 and IRAK2, and then this is followed by the recruitment 
and oligomerization of tumour necrosis factor–associated factor (TRAF) 6 [Cao Z et al., 
1996; Kawagoe T et al., 2008]. In response to ligand binding of the receptor and the initial 
receptor-proximal signalling, a complex cytosolic sequence of combinatorial 
phosphorylation and ubiquitination events results in activation of nuclear factor B signalling 
(NF-κB,) and the JNK and p38 mitogen-activated protein kinase (MAPK) pathways, which, 
cooperatively, induce the expression of canonical IL-1 target genes (such as IL-6, CXCL8, 
CCL2, PTGS2, IκBα, IL-1α, IL-1β, MKP-1) by transcriptional and posttranscriptional 
mechanisms [Weber A et al., 2010] (Figure 3). Specific signaling pathways mediate IL-1β 
actions in different cell types. For instance, IL-1β activates the p38/CREB signaling pathway 
in hippocampal neurons, in contrast to the activation of NF-κB in glial cells, demonstrating 
cell type-specific signaling responses to IL-1 in the brain and yielding distinct functional 
responses [Srinivasan D et al., 2004]. 
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Figure 3. The central signaling module of the IL-1R complexes. Ligand-
induced formation of the trimeric IL-1R complex (or other IL-1family receptor 
complexes) leads to the intracellular formation of the TIR:TIR scaffold. The 
recruitment of several MyD88 molecules recruitment to the scaffold via homotypic 
TIR domain interaction allows further recruitment of IRAK4, first, and then of 
IRAK1 and/or IRAK2 (not depicted here). IRAK4 subsequently phosphorylates 
IRAK1 and IRAK2, and then the recruitment and oligomerization of tumour 
necrosis factor–associated factor (TRAF) 6 follows. This is followed by a complex 
cytosolic sequence of combinatorial phosphorylation and ubiquitination events 
resulting in the activation of nuclear factor B signalling (NF-κB) and the JNK and 
p38 mitogen-activated protein kinase pathways (Adapted from: Boraschi et al., 
Immunological Reviews 2018) 
 
 
1.1.3 IL-1β Synthesis, Processing and Release 
 
IL-1β is first synthesized as biologically inactive 31 kDa precursor peptide (pro-IL-1β), 
which can be cleaved by caspase-1 to generate a 17 kDa mature and biologically active 
form (mIL-1β) that is subsequently released into the extracellular milieu [Mosley B et al., 
1987; Black RA et al., 1988; Eder C, 2009]. 
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This cytokine lacks a leader peptide and is therefore secreted via an unconventional 
pathway, independent of the endoplasmic reticulum and Golgi apparatus. Production of 
proinflammatory (pro)–IL-1β is induced by Toll-like receptor (TLR)-mediated NF-κB 
activation [Gabay C et al., 2010]. IL-1β is processed and released from cells by a 
mechanism involving caspase 1 [Thornberry NA et al., 1992]. Activation of caspase 1 is 
regulated by a multimeric cytosolic protein complex, called the inflammasome [Fettelschoss 
A et al., 2011]. Inflammasomes are large (~1 μm) intracellular protein complexes that 
comprise a pattern recognition receptor (PRR), an adapter molecule and the enzyme 
caspase-1 [Schroder K and Tschopp J, 2010]. The best characterised inflammasome is 
known as the NLRP3 inflammasome, so-called because the PRR molecule is nucleotide-
binding oligomerisation domain (NOD)-like receptor, pyrin-containing 3 (NLRP3) [Daniels 
MJ and Brough D, 2017]. 
Following caspase-1-dependent processing of pro-IL-1β [Brough D and Rothwell NJ, 2007], 
pro-IL-1β remains cell-associated until a second stimulus (a further PAMP or DAMP) 
triggers processing and secretion of the mature cytokine. However, how IL-1β is secreted 
from the cell is not clear. Multiple observations and proposals have been made that do not 
converge on a single unified mechanism of secretion, but rather suggest that there may be 
multiple mechanisms. These of course may not be mutually exclusive but may each make 
a specific contribution to IL-1β-dependent inflammation [Lopez-Castejon G and Brough D, 
2011]. 
Perhaps the best characterised mode of release is secretion tightly coupled to pyroptotic 
cell death. Pyroptosis is a form of inflammatory cell death characterised by the concomitant 
release of IL-1β and IL-18 [Bergsbaken T et al., 2009] and can be induced by NLRP3-
activating stimuli such as ATP binding to the extracellular ATP receptor P2X7 [Perregaux 
D and Gabel CA, 1994; Ferrari D et al., 1994]. This pathway of cell death is uniquely 
dependent on caspase-1, which is not involved in apoptotic cell death, and caspase-1-
deficient cells respond normally to most apoptotic signals. Unlike apoptosis, which has an 
anti-inflammatory outcome, cell death by pyroptosis results in plasma-membrane rupture 
and the release of damage-associated molecular pattern (DAMP) molecules into the 
extracellular milieu, including cytokines that recruit more immune cells and further 
perpetuate the inflammatory cascade in the tissue [Fink SL and Cookson BT, 2005].  
However, recent studies demonstrated that IL-1β can be secreted both in an active 
mechanism independent of cell death but also in a manner that absolutely requires loss of 
membrane integrity [Daniels MJ and Brough D, 2017] (Figure 4). 
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Figure 4. Steps in the processing and release of IL-1 induced by IL-1. (1) 
Mature IL-1β or the IL-1α precursor activates IL-1 intracellular signalling, which 
starts with the formation of the IL-1 receptor complex heterodimer comprising IL-
1RI and IL-1RAcP. (2) This leads to the proximity of the intracellular TIR domains. 
(3) Recruitment of MyD88 and phosphorylation of IL-1R–associated kinases 
(IRAKs) and inhibitor of NFB kinase β (IKKβ). (4) Transcription of IL-1β. (5) 
Translation of IL-1β mRNA into IL-1β takes place on polysomes. IL-1β mRNA is 
not bound to actin microfilaments but rather intermediate filaments. (6) ATP 
released from the activated monocyte/macrophage accumulates extracellularly. 
(7) Activation of the P2X7 receptor by ATP. (8) Efflux of potassium from the cell 
after ATP binding to P2X7 receptor. (9) Fall in intracellular levels of potassium, 
which triggers (10) the assembly of the components of the caspase-1 
inflammasome with the conversion of procaspase-1 to active caspase-1. (11) 
Caspase-1 is found in the secretory lysosome together with the IL-1β precursor 
and lysosomal enzymes. Active caspase-1 cleaves the IL-1β precursor in the 
secretory lysosome, generating the active, carboxyl-terminal mature IL-1β. (12) 
An influx of calcium with an increase in intracellular calcium levels. The rise in 
intracellular calcium activates phosphatidylcholine-specific phospholipase C and 
calcium-dependent phospholipase A. (13) The release of mature IL-1β, the IL-1β 
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precursor, and the contents of the secretory lysosomes by exocytosis in the 
absence of cell death. (14) Processing of the IL-1β precursor in the cytosol. 
Rab39a, a member of the GTPase family, contributes to the secretion of IL-1β by 
helping traffic from the cytosol into a vesicle compartment. Exocytosis is another 
mechanism described in mouse macrophages. (15) Mature IL-1β exits the cells 
via loss in membrane integrity, associated with the release of lactic 
dehydrogenase or microvesicles. (Adapted from: Charles A. Dinarello, Blood 
2010) 
 
 
Two signals have been proposed to be required for IL-1β release from primary 
macrophages: first, activation of Toll-like receptors (TLRs), resulting in transcription and 
translation of pro-IL-1β; and second, NLR-induced IL-1β processing and release through a 
caspase-1-dependent mechanism involving P2X7 receptor activation by extracellular ATP 
[Arend WP et al., 2008]. Different models for a non-classical secretory pathway to release 
IL-1β have been recently described for different cell types (e.g. 
monocytes, macrophages, dendritic cells and brain microglia). For instance, five different 
release mechanisms have been suggested by Claudia Eder and colleagues in 2009: 
(1) exocytosis of IL-1β-containing secretory lysosomes, (2) release of IL-1β from shed 
plasma membrane microvesicles, (3) fusion of multivesicular bodies with the plasma 
membrane and subsequent release of IL-1β-containing exosomes, (4) export of IL-1β 
through the plasma membrane using specific membrane transporters, and (5) release of IL-
1β upon cell lysis [Eder C, 2009]. 
In 2011, Gloria Lopez-Castejon and David Brough [Lopez-Castejon G and Brough D, 2011] 
proposed three categories of secretion mechanism: Rescue and redirect, protected release 
and terminal release. The rescue and redirect hypothesis is based on the observed fraction 
of cellular IL-1β localised to vesicles of endolysosomal nature that is targeted for 
degradation, but that can be redirected to the extracellular space following an appropriate 
secretion stimulus [Andrei C et al., 1999, 2004]. The protected release mechanism is based 
upon the observation that bioactive IL-1β can be found in shed microvesicles originated 
from the plasma membrane [MacKenzie A et al., 2001; Bianco F et al., 2005] and secreted 
exosomes [Qu Y et al., 2007]. Since it is known that IL-1β has a very short half-life in plasma, 
it is conceivable that the protected cytokine is destined to reach sites that are distant from 
the inflammatory lesion. Lastly, terminal release has been proposed to occur under 
conditions of extreme inflammatory stress and involves a commitment to cell death. Indeed, 
this mechanism allows a rapid release of large quantities of active IL-1β directly across a 
disintegrating plasma membrane. However, given the diversity of secretion stimuli, culture 
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conditions and cell types that secrete IL-1β, elucidating the precise mechanisms by which 
IL-1β is secreted remains a considerable challenge. It might be possible that all 
mechanisms contribute simultaneously to the secretion of IL-1β [Lopez-Castejon G and 
Brough D, 2011]. 
It has been reported that in activated monocytes a microvesicle shedding from plasma 
membrane is the major secretory pathway for rapid IL-1β release [MacKenzie A et al., 
2001]. Another fraction of cellular IL-1β is released by the regulated secretion of late 
endosomes and early lysosomes, and this may represent a cellular compartment where 
caspase-1 processing of pro-IL-1β takes place. In a first step, pro-caspase-1 and endotoxin-
induced pro-IL-1β are targeted in part to specialized secretory lysosomes, where they 
colocalize with other lysosomal proteins. Externalization of mature IL-1β and caspase-1 
together with lysosomal proteins is then facilitated by extracellular ATP which triggers the 
efflux of K+ from the cell, followed by Ca2+ influx and activation of three phospholipases: 
phosphatidylcholine-specific phospholipase C (PC-PLC) and calcium-independent (iPLA2) 
and -dependent phospholipase A2 (cPLA2). Whereas calcium-independent phospholipase 
A2 is involved in processing, phosphatidylcholine-specific phospholipase C and calcium-
dependent phospholipase A2 are required for secretion. In particular, the ATP-mediated 
K+ efflux is responsible for phosphatidylcholine-specific phospholipase C induction, which 
in turn allows the rise in intracellular free calcium concentration required for activation of 
phospholipase A2. This activation is ultimately responsible for lysosome exocytosis and IL-
1β secretion [Andrei C et al., 2004]. Although it has been already proposed that iPLA2 is 
required to facilitate passage of caspase-1 to pro-IL-1β and, consequently, pro-IL-1β 
processing [Walev I et al., 2000], the molecular nature of a lysosomal transporter for IL-
1β – should one exist – is unknown. 
 
 
1.1.4 IL-1β and Inflammation 
 
More than any other cytokine family, the IL-1 family of ligands and receptors is 
primarily associated with acute and chronic inflammatory diseases (Table 2). 
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Table 2  Interleukin-1 in the pathogenesis and treatment of 
acute and chronic inflammatory diseases  
 
(Adapted from: Charles Dinarello, The American Journal of Clinical 
Nutrition 2018) 
 
 
IL-1 was initially described for its ability to affect various and different biological properties 
but, for many years, it remained uncertain whether a single polypeptide was indeed capable 
of such a range of distinctly different biological properties. It was a highly contentious issue 
that a single molecule could cause fever, induce hepatic acute-phase proteins, activate 
lymphocytes, and upregulate prostanoid synthesis. The cloning of IL-1 cDNAs [Lomedico 
PT et al., 1984; Auron PE et al., 2007] and, soon thereafter, the introduction of recombinant 
IL-1 showed that this protein did in fact possess such a wide spectrum of biological activities 
and was indeed pyrogenic [Dinarello CA et al., 1986]. In 1984 it was predicted that IL-1 was 
responsible for many of the acute-phase responses to infection and inflammation [Dinarello 
CA, 1997]. In addition, recombinant IL-1 was found to mediate many components of the 
acute-phase response. This evidence demonstrated that IL-1 causes a wide variety of 
biological effects associated with infection, inflammation, and autoimmune processes 
[Dinarello CA et al., 1986]. In many ways, the biology of IL-1 played a major role in the new 
field of cytokines [Dinarello CA, 2006]. IL-1β has emerged as a therapeutic target for an 
17 | P a g .  
 
expanding number of local and systemic inflammatory conditions called autoinflammatory 
diseases. Autoinflammatory syndromes are distinct from autoimmune diseases. In 
autoimmune diseases, dysfunctional T cell are associated with the pathogenesis of the 
disease as they drive inflammation. Immunosuppressive therapies targeting T-cell function, 
as well as antibodies that deplete T and B cells, are effective in treating autoimmune 
diseases. In contrast, in autoinflammatory diseases, the dysfunctional cells which directly 
promote inflammation are monocytes-macrophages. Autoinflammatory conditions are 
characterized by recurrent bouts of fever with debilitating local and systemic inflammation. 
In general, these diseases are poorly controlled with immunosuppressive therapies, but 
they are often responsive to pharmacological therapies based upon IL-1β inhibition (Table 
2). Although some autoinflammatory diseases are due to gain-of-function mutations for 
caspase-1 activity, common diseases such as gout, type 2 diabetes, heart failure, recurrent 
pericarditis, rheumatoid arthritis, and smoldering myeloma also are responsive to IL-1β 
neutralization, which results in a rapid and sustained reduction in disease severity [Dinarello 
CA, 2018]. 
 
 
1.2 IL-1 in the Brain 
 
A cytokine, in order to have an effect in the brain, needs to fulfill two conditions: (1) it 
must be detectable in its biological active form in the extracellular milieu and (2) the target 
cells must express the appropriate receptors on their plasma membrane. Previous studies 
demonstrated constitutive expression of mRNA for IL-1α and IL-1β in cerebellar Purkinje 
cells, hypothalamic neurons and in the hippocampus, mainly in the granule cells of the 
dentate gyrus [Yabuuchi et al., 1993]. It is now well established that IL-1RI is expressed 
throughout the brain, with the highest levels found in cerebral cortex and hippocampus 
[Farrar WL et al., 1987; Takao T et al., 1990; Ban EM, 1994; Gabellec MM et al., 1995; 
French RA et al., 1999; Eriksson C et al., 2000]. All members of the IL-1 family (i.e., IL-1, 
IL-1Ra, IL-1RI, IL-1RII, and IL-1RAcP) are expressed in the healthy CNS. Low levels of IL-
1β immunoreactivity have been detected throughout the brain of rodents in normal 
conditions, with highest expression occurring in the hippocampus, hypothalamus, and basal 
forebrain [Breder CD et al., 1988; Lechan RM et al., 1990; Molenaar GJ et al., 1993; 
Hammond EA et al., 1999]. The cell types capable of synthesizing IL-1 - microglia [Giulian 
D et al., 1986; Hetier E et al., 1988; Yao J et al., 1992], astrocytes [Lieberman AP et al., 
1989; Tomozawa Y et al., 1995; Knerlich F et al., 1999; Zhang W et al., 2000], 
oligodendrocytes [Blasi F et al., 1999], and neurons [Lechan RM et al., 1990; Takao T et 
al., 1990; Watt JA and Hobbs NK, 2000] - also express the signalling receptor [Hammond 
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EA et al., 1999; Friedman WJ, 2001; Pinteaux E et al., 2002; Wang XF et al., 2006]. Finally, 
IL-1RAcP - the protein necessary for signal transduction via IL-1RI to occur - is also 
expressed in the rat brain under normal physiological conditions, with particularly elevated 
levels in the hypothalamus, cortex, hippocampus, and cerebellum [Liu C et al., 1996; Ilyin 
SE et al., 1998]. Expression of IL-1α and β, IL-1Ra, and IL-1 receptors has also been 
demonstrated in postmortem human brain [Sheng JC et al., 1998; Huitinga I et al., 2000; 
Toyooka K et al., 2003]. Although cell type-specific expression of the IL-1 family in human 
tissue has not been investigated thoroughly, IL-1 and IL-1Ra RNA can be detected in 
cultured human microglia [Walker DG et al., 1995] and IL-1 immunoreactivity is present in 
human neurons [Huitinga I et al., 2000; Fogal B and Hewett SJ, 2008]. 
 
 
1.2.1 IL-1 in Brain Development 
 
IL-1 is detectable by immunohistochemistry in the developing mammalian brain as early as 
the time of formation of the cortical plate [Dziegielewska KM et al., 2000], but important 
amounts are not detectable before the end of the period of intense cortical neurogenesis 
[Caviness VS et al., 2008]. The observation of a peak in IL-1β expression, described in the 
late prenatal and early postnatal periods [Giulian D et al., 1988], suggests an involvement 
of this cytokine in synaptogenesis and neuronal network reorganisation, with significant 
impact on the development of behavioural patterns [Kaffman A and Meaney MJ, 2007]. The 
delayed effects of prenatal exposure to IL-1 emphasizes the putative role played in the 
developing brain. Indeed, exposure to IL-1 in mice around E15-17 results in schizophrenia-
like behavior late in adulthood [Zaharia MD et al., 1996; Ozawa K et al., 2006]. Therefore, 
although IL-1 is required for normal brain development [Giulian D et al., 1988], exposure to 
excessively high levels becomes detrimental [Zuckeman L and Weiner I, 2005; Ozawa K et 
al., 2006]. This late consequence might be due to the effect of IL-1 exposure to the 
developing brain cells that know to be associated with schizophrenia (i.e. pyramidal cells, 
medium spiny neurons (MSNs) and certain interneurons, and to a smaller extent, 
embryonic, progenitor or glial cells) [Skene NG et al., 2018]. Moreover, previous studies 
specifically focusing on the dopaminergic system gave a clear evidence concerning the 
implication of IL-1 in dopaminergic neuron development in the CNS. In fact, it has been 
demonstrated that IL-1 is necessary to induce the proliferation of mesencephalic 
dopaminergic progenitors and promote their differentiation into adult dopamine producing 
neurons from long-term cultures of human fetal mesencephalic precursor cells [Ling ZD et 
al., 1998; Storch A et al., 2001].  
 
19 | P a g .  
 
1.2.2 IL-1 and Behaviour 
 
Several behavioural elements are known to be modulated and influenced by 
cytokines: modulation of pain [Wolf G et al., 2003], anxiety [Anisman H and Merali Z, 1999], 
learning and memory [Pickering M and O'Connor JJ, 2007; reviewed in Pozzi D et al., 2018], 
and sickness behaviour [Konsman JP et al., 2002].  
IL-1β is among the main pro-inflammatory cytokines involved in sickness syndrome, which 
is a normal, very well organized, non-specific adaptive response to infection that it is 
characterized by endocrine, autonomic and behavioural changes and is triggered by soluble 
mediators that are produced at the site of infection by activated accessory immune cells. 
These pro-inflammatory mediators, including IL-1α, IL-1β, TNF-α andIL-6, coordinate the 
local and systemic inflammatory response to microbial pathogens. These peripherally 
produced cytokines also act as humoral messengers conveying the signals from the 
periphery to the brain to cause the typical behavioral symptoms of sickness, including 
lethargy, depression, anxiety, malaise, loss of appetite, sleepiness, hyperalgesia, failure to 
concentrate, usually accompanied by fever [for review see Johnson RW, 2002; Dantzer R 
and Kelley KW, 2007]. Two mechanisms mediating the behavioral effects of peripherally 
released cytokines on the brain have been proposed: (1) a fast neural route represented by 
the primary afferent neurons that innervate the body site where the infectious process takes 
place and (2) a slower humoral pathway that involves the production of proinflammatory 
cytokines by phagocytic cells in response to circulating PAMPs or cytokines, followed by 
the propagation of these immune signals into the brain parenchyma [Danzer R, 2009]. 
Besides the well-established contribution of IL-1β to sickness, it has been widely elucidated 
also its involvement a variety of diseases. There is now a growing body of evidence pointing 
toward cognition as a shared physiological process hit by this cytokine. This concept 
originally emerged from a series of pioneering experiment showing that the intraperitoneal 
or intrahippocampal injection of this cytokine results in learning and memory defects. Many 
studies based on exogenous administration of IL-1β reported long-term memory deficits, 
although some of them pointed out the possibility that the memory deficits may be the 
consequence of the sickness syndrome induced by IL-1β rather than being attributed to any 
direct effect on memory consolidation [Cunningham C and Sanderson DJ, 2008]. 
Nevertheless, in vitro data support a direct effect on hippocampal LTP, which may be 
obscured by the more prominent symptoms of the sickness syndrome [O'Connor JJ and 
Coogan AN, 1999].  
The detrimental effects of IL-1β on cognition were later confirmed using transgenic mice 
expressing the cytokine in an inducible manner or upon endogenous IL-1β elevations 
evoked by infections, with the memory deficits being prevented, in the latter case, by intra-
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ventricular infusion of the naturally occurring interleukin-1 receptor antagonist (IL-1Ra). 
Previous reports also demonstrated that brain IL-1 facilitates learning of a water maze 
spatial memory task in young mice and that, on the other hand, impaired Interleukin-1 
signalling is associated with deficits in hippocampal memory processes [Avital A et al., 
2003; Takemiya T et al., 2017]. In particular, it has been reported that the IL-1R antagonist 
(IL-1Ra) impaired memory in the water maze and passive avoidance paradigms, whereas 
IL-1β administration facilitated memory in the passive avoidance test [Yirmiya R et al., 
2002]. IL-1 receptor type I knockout (IL-1R KO) [Labow M et al., 1997; Glaccum MB et al., 
1997] mice have been used to further examine the hypothesis that IL-1 signalling pathways 
are involved in the physiological mechanisms that control learning, memory, and neural 
plasticity. For instance, IL-1R KO mice were studied in several paradigms of memory 
function and hippocampal plasticity. In the spatial version of the water maze test, IL-1R KO 
mice displayed signiﬁcantly longer latency to reach a hidden platform, compared with wild-
type controls; furthermore, IL-1R KO exhibited diminished contextual fear conditioning, but 
were similar to control animals in hippocampal-independent memory tasks [Avital A et al., 
2003]. 
 
 
1.2.3 IL-1β, Neuroinflammation and Neurodegeneration 
 
Inflammation is generally a beneficial response of an organism to infection but, when 
prolonged or inappropriate, it can be detrimental. Neuronal loss in acute (e.g. stroke and 
head injury) and chronic (e.g. multiple sclerosis and Alzheimer’s disease) central nervous 
system diseases has been associated with inflammatory processes systemically and in the 
brain. Within the nervous tissue, neuroinflammation is conventionally considered as the 
ability of the central (CNS) and peripheral (PNS) nervous system to mount an innate 
immune response during a pathological event. The tissue resident microglia and astroglia 
are considered the hallmark effector cells involved in mounting inflammatory responses to 
injury [Allan SM et al., 2005]. However, the fine balance of governing neuroinflammation 
within the mammalian CNS is a challenging feat which is often associated with a bystander 
effect leading to exacerbated tissue damage. 
Brain inflammation induces rapid expression and release of key inflammatory mediators – 
cytokines, chemokines, prostaglandins and complement proteins – which in turn up-
regulate adhesion molecules, increase permeability of the blood–brain barrier facilitating 
the invasion of peripheral immune cells, induce release of potentially toxic molecules and 
compromise brain cells. Cytokines are primary mediators of the inflammatory response and 
special attention has been given to the balance between proinflammatory (e.g. IL-1, IL-6, 
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TNF-α, IL-18) and anti-inflammatory (IL-4, IL-10, TGF-β) cytokines. As mentioned above, a 
central role of IL-1β in mediating neuroinflammation has been recognized in most CNS-
related diseases including stroke, traumatic brain injury, Alzheimer’s disease and multiple 
sclerosis, and diseases that affect the ocular system including diabetic retinopathy 
[Mendiola AS and Cardona AE, 2017]. 
Microglia represent the main source of IL-1 in the brain upon injury and in neuroinflammation 
[Yabuuchi K et al., 1993; Eriksson C et al., 1999], with induction occurring within an hour of 
the onset [Giulian D and Lachman LB, 1985; Yabuuchi K et al., 1993; Eriksson C et al., 
1998; Eriksson C et al., 1999], linking IL-1 to the neurodegenerative process. Interestingly, 
the endogenous antagonist (IL-1Ra) is induced in the same cell types that express IL-1R 
agonist, but with a certain delay [Eriksson C et al., 1998; Eriksson C et al., 2000]. The lower 
severity of brain injury and improved recovery upon blocking IL-1 signalling [Tehranian R et 
al., 2002] further support the implication of IL-1 in neurodegeneration.  
 
 
1.2.4 IL-1β, Microglia and Neuroinflammation  
 
Simultaneous increased expression of IL-1 and microglia activation in the CNS are 
frequently associated with neuroinflammation and considered indicators of pathogenesis in 
CNS diseases. Indeed, in numerous studies, elevated levels of IL-1 and changes in 
microglial morphology have been used as hallmarks of CNS inflammation. Based on the 
notion that IL-1 stimulates monocytes/macrophages (the peripheral counterparts of 
microglia) to amplify inflammation in the peripheral immune system, it has been proposed 
a central role for CNS IL-1 and microglia in influencing functions of the nervous system. 
Although the central nervous system exhibits immunological privileges that restrict 
amplification of inflammation to stringent control, it is now clear that increased CNS IL-1 
expression together with microglial activation amplifies neuroinflammation contributing to 
neuropathology. However, microglia participate in many neural functions that are not related 
to immunological activities, and several studies evaluate the contribution of immunological 
and non-immunological aspects of microglia/IL-1 interaction in the CNS and how these 
aspects might affect health and disease in the nervous tissue [for review see Liu X and 
Quan N, 2018]. 
CNS glia (microglial cells and astrocytes) produce and release high amount of IL-1β 
under conditions of damage, stress, and disease and this cytokine induces production of 
additional pro-inflammatory cytokines and growth factors, thereby promoting inflammatory 
activity in the brain [Benveniste EN, 1992; Merrill JE and Benveniste EN, 1996]. The main 
source of IL-1 is microglial cells, which have also been suggested as targets for its action. 
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Microglia are resident cells of the brain involved in regulatory processes critical for 
development, maintenance of the neural environment, response to injury, and subsequent 
repair. Microglia sense pathological events in the CNS and serve as brain immune cells to 
orchestrate innate immune responses. They are the resident mononuclear phagocytes of 
the central nervous system and share phenotypic characteristics and innate immunological 
functions with other mononuclear phagocytes. Similar to macrophages, M1 polarized 
microglia can produce pro-inflammatory cytokines and mediators such as interleukin IL-1β, 
IL-6, tumor necrosis factor-α, CC-chemokine ligand 2, nitric oxide, and reactive oxygen 
species, suggesting that these molecules contribute to dysfunction of neural network in the 
CNS. On the other hand, M2 polarized microglia can produce anti-inflammatory cytokines, 
such as IL-10, and express several receptors that are implicated in inhibiting inflammation 
and restoring homeostasis. Given the diversity, plasticity, and immunoregulatory functions 
of M1 and M2 microglia in neurodegenerative and neurological disorders, it has been 
proposed that an imbalance between M1 and M2 polarization of microglia contributes to 
these pathological conditions [Nakagawa Y and Chiba K, 2014] (Figure 6).   
 
Figure 5. M1/M2 polarization of microglia and their immunoregulatory 
functions. Resting microglial cells are stimulated with PAMPS or DAMPS via 
TLR or ATP receptors. In the presence of LPS and IFN-γ, microglial cells 
polarize to M1 phenotype and produce pro-inflammatory cytokines/mediators 
including IL-1β, IL-6, TNF-α, CCL2, ROS, and NO. In contrast, IL-4 and IL-13 
induce alternative activation of microglia to M2 (‘M2a’) phenotype which down-
regulates M1 functions by anti-inflammatory cytokine, IL-10. (Adapted from: 
Yutaka Nakagawa and Kenji Chiba, Pharmaceuticals (Basel) 2014) 
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1.2.5 IL-1β and Synapses 
 
The hippocampus is one of several brain regions that together comprise the 
hippocampal formation. The hippocampal formation is a prominent C-shaped structure 
bulging in the floor of the temporal horn of the lateral ventricle and consisting of four 
cytoarchitectonically distinct regions: the entorhinal cortex, the dentate gyrus, the subicular 
complex and the hippocampus proper. The hippocampus proper consists of three major 
subfields (CA1, CA2 and CA3). The hippocampus is an anatomical component of the limbic 
system and has extensive connections with the sensory, as well as with the motor cortices. 
Based on its extrinsic connectivity, the hippocampal formation receives a vast amount of 
highly processed multimodal sensory information that is funneled into the hippocampal 
formation mainly by the entorhinal cortex, which is connected to associational neocortical 
areas in a reciprocal manner. Extensive hippocampal integration of sensory information is 
established by a largely unidirectional chain of intrinsic hippocampal projections. Indeed, 
the hippocampus features a unique unidirectional excitatory projection pattern which starts 
in the entorhinal cortex that projects to the dentate gyrus via the perforant pathway. The 
granule cells of the dentate gyrus project to the CA3 subfield of the hippocampus proper via 
the mossy fibres. The CA3 pyramidal neurons give rise to association fibres terminating in 
the contralateral CA3 as well as to projections further to the CA1 subfield via the Schaffer 
collaterals. The subicular complex is the target for the main output pathway of the CA1 
pyramidal cells. Even if the current knowledge on hippocampal connectivity and function is 
largely based on studies of rodents and monkeys and it still remains to be determined to 
which extent such neuroanatomical data of experimental animals is applicable to the human 
hippocampal formation, there is a compelling evidence for a key role of the hippocampal 
formation in memory and learning. 
The prominent effect of IL-1 in such behavioural processes indicates that the cytokine 
may directly affect neuronal and synaptic function. Neurons in the hippocampus also 
express the type 1 IL-1 receptor, indicating that this cytokine can influence neuronal function 
directly, also regulating synaptic function of hippocampal neurons with consequences on 
the modulation of long-term potentiation (LTP) [Katsuki H et al., 1990; Bellinger FP et al., 
1993; Murray CA and Lynch MA, 1998; Kelly A et al., 2001; Srinivasan D et al., 2004]. In 
line with the induction of cognitive defects, excessive IL-1β affects long-term potentiation 
(LTP), the synaptic process which underlies learning and memory. Indeed, it has been 
demonstrated that high concentrations of IL-1 act upon neurons to inhibit synaptic strength 
and LTP [Katsuki H et al., 1990; Bellinger FP et al., 1993; Murray CA and Lynch MA, 1998]. 
in several regions of the hippocampus, including CA1 [Bellinger FP et al., 1993; Ross FM 
et al., 2003], CA3 [Katsuki H et al., 1990], and dentate gyrus [Murray CA and Lynch MA, 
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1998; Kelly A et al., 2003]. Of note, the synaptic potentiation processes are not only affected 
in different pathological scenarios, but also during aging, when the overproduction of IL-1β 
and/or a synapse-specific IL-1 receptor subunit reconfiguration may produce specific 
deficits in consolidation of hippocampus-dependent memory [Patterson SL, 2015; Prieto 
GA et al., 2015] and also during stress-related conditions, a particular pathophysiological 
state which might deeply affect immature brain [Barron H et al., 2017; Depino AM, 
2017; Schiavone S and Trabace L, 2017]. In contrast, physiological levels of IL-1 promote 
LTP and memory formation [Yirmiya R et al., 2002]. The distinct functions of IL-1 are 
mediated through the same type 1 IL-1 receptor (IL-1R1), which is expressed and regulated 
by IL-1 in both hippocampal neurons and glial cells [Friedman WJ, 2001]. However, the 
signalling pathways for IL-1 in these cell types differ [Srinivasan D et al., 2004]: the pathway 
involving activation of the three MAPKs (ERK, JNK, and P38) is present only in neurons 
[Huang Y et al., 2011]. 
IL-1β and its receptors have important roles in a wide range of processes, including 
neurogenesis and synapse formation and plasticity, from early prenatal CNS development 
to postnatal development and adulthood [de la Mano A et al., 2007; Yoshida T et al., 2011; 
Valnegri P et al., 2011; Yoshida T et al., 2012]. IL-1β exerts its biological functions by 
activating the IL-1R1 and then recruiting a signalling core complex consisting of the myeloid 
differentiation primary response protein 88 (MyD88) and the IL-1R accessory protein (IL-
1RAcP). Although this pathway has been clearly described in the peripheral immune 
system, very limited information about the molecular composition and distribution of its 
members in neuronal cells are available. Recent findings showed that IL-1R1, as well as its 
accessory proteins MyD88 and IL-1RAcP, are differently distributed in the hippocampus 
and in the subcellular compartments of primary hippocampal neurons in primary cultures. 
In particular, IL-1R1 and IL-1RAcP are enriched at synaptic sites, where they co-localise 
with and bind to the GluN2B subunit of NMDA receptors (Figure 5) [Gardoni F et al., 2011].  
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Figure 6. Synaptic modulation by IL-1β, its receptors and related 
proteins.  Interleukin‑1β (IL-1β) exerts distinct effects at the synapse. Binding of 
IL-1β to IL‑1 receptor type 1 (IL‑1R1) recruits the IL‑1 receptor accessory protein 
(IL-1RAcP), which increases NMDAR signaling. Unbound IL-1RAcP acts as a 
trans-synaptic adhesion molecule through its interactions with presynaptic protein 
tyrosine phosphatase-σ (PTPσ), PTPδ and leukocyte common antigen related 
(LAR). Another member of the IL-1 receptor family, IL-1R accessory protein-like 
receptor 1 (IL-1RAPL1), also acts as a synaptic organizer by binding to 
presynaptic PTPδ. These trans-synaptic interactions exert multiple effects on 
synapse formation and plasticity. (Adapted from: Myka L. Estes and A. 
Kimberley McAllister, Nature Review Neuroscience 2015) 
 
 
Furthermore, it has been observed that treatment with NMDA increases IL-1R1 interaction 
with NMDA receptors, as well as the surface expression and localization of IL-1RI at 
synaptic membranes. IL-1β also increases IL-1R1 levels at synaptic sites, without affecting 
the total amount of the receptor in the plasma membrane. These results confirmed the 
existence of a dynamic and functional interaction between IL-1RI systems and NMDA 
receptors that could provide a molecular basis for IL-1β as a neuromodulator in 
physiological and pathological conditions relying on NMDA receptor activation. They also 
suggested a possible involvement and contribution of IL-1β to excitotoxicity, thus opening 
up new possibilities for targeted inhibition strategies that can be used in IL-1β/glutamate-
driven CNS diseases [Gardoni F et al., 2011]. 
In the last decade, extensive evidence has pointed to the concept that IL-1β directly affects 
synapse structure and function. Indeed, experiments performed in primary cultured neurons 
exposed to recombinant IL-1β revealed a significant decline in the levels of the presynaptic 
vesicle protein synaptophysin [Li Y et al., 2003], most likely through regulation of 
presynaptic functionalities by retrograde mechanisms from the postsynaptic site, and in the 
number of synaptic sites [Mishra A et al., 2012]. The occurrence of the harmful cytokine 
effects on the synapse structure has been reported also in different non-neurological 
disorders associated to increased IL-1β levels, like sepsis and obesity, where mice show 
memory impairment and reduced number of hippocampal and cortical excitatory synapses, 
through a mechanism fully prevented by the addition of IL-1Ra [Erion JR et al., 
2014; Moraes CA et al., 2015]. 
Different mechanisms have been taken into account to clarify the association between 
excessive IL-1β levels and synaptic alterations, including the modulation of the mitogen-
activated protein kinase (MAPK) pathway and the modification of trophic factor production, 
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such as brain-derived neurotrophic factor (BDNF) [Patterson SL, 2015]. Although it is still 
unclear whether IL-1β may directly act on neuronal proteins involved in modulating the 
structure and function of dendritic spines and known to be the molecular targets of 
synaptopathies, it is now an accepted fact that inflammation is an important contributor to 
defects in brain function, by affecting in particular cognitive processes [Rachal Pugh C et 
al., 2001; Huang ZB and Sheng GQ, 2010; Yirmiya, R and Goshen I, 2011] through 
concentration-dependent detrimental effects induced by the pro-inflammatory cytokine IL-
1β. Indeed, recent reports have highlighted the ability of IL-1β to selectively affect cell-to-
cell communication in the brain, by targeting specific synaptic pathways [Mishra A et al., 
2012; Han Q et al., 2017] which are known to be altered in different synaptopathies. 
 
 
1.2.6 Microglia and the Process of Synaptic Pruning 
 
Microglia play a central role in the cellular response to pathological lesions and are 
key players in brain injury and disease [Kreutzberg GW, 1996; Ransohoff RM and Perry 
VH, 2009; Kettenmann H et al., 2011]. However, they were recently shown to play 
unexpected functions in normal brain development and adult physiology, suggesting 
potential roles in postnatal development, adult neuronal plasticity, and circuit function 
(Figure 7).   
 
Figure 7. Overview of microglial behavior in the healthy brain. Highly motile 
microglial processes continuously remodel their local environment (left), 
structurally and functionally interact with synaptic elements (middle; dendritic 
branch and spines, green) through direct contacts and exchanges of molecular 
signals and contribute to restructuring of neuronal circuits by phagocytosing 
synaptic elements and newborn cells (right; cellular inclusions, blue and green). 
Microglial morphology and behavior display variability across CNS regions and 
stages of the lifespan. (Adapted from: Marie-Ève Tremblay et al., Journal of 
Neuroscience 2011) 
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Microglial phagocytosis of apoptotic newborn neurons is very important in the process of 
neurogenesis. In the adult hippocampus, stem and progenitor cells persist in the 
subgranular zone (SGZ) of the hippocampal dentate gyrus and give rise to newborn granule 
cells that mature and integrate into the hippocampal circuitry over a period of a month 
[Kempermann G et al., 2004]. While these newborn cells participate in some forms of 
learning and memory, mood regulation, and fear conditioning [Kempermann G, 2008; Ming 
GL and Song H, 2011], the majority are pruned early during their development and undergo 
apoptosis in the first few days of cell life. In this basal condition, phagocytosis is performed 
by ramified, unchallenged microglia [Sierra A et al., 2010], in contrast to the phagocytosis 
by amoeboid microglia observed during neurodegeneration [Kettenmann H, 2007]. 
Microglia are also involved in postnatal developmental synaptic refinement as they 
phagocytose extranumerary synapses (Figure 8). Indeed, the first 2 weeks of postnatal 
development are a period of remarkable plasticity with new synapses being actively formed 
and remodelled. Initially, neurons make far more synaptic connections than are maintained 
in the mature brain. During an activity-dependent developmental process termed synaptic 
pruning, a large number of these immature synapses are permanently eliminated while a 
subset of synapses is maintained and strengthened [Katz LC and Shatz CJ, 1996; Hua JY 
and Smith SJ, 2004; Huberman A et al., 2008]. Furthermore, a recent study also suggested 
that microglia participate in slower, experience-dependent remodelling and elimination of 
synapses in the mature healthy brain [Tremblay MÈ et al., 2010] (Figure 8), contributing to 
the reorganization of neuronal circuits. Microglial cells are also involved in adult circuit 
plasticity and function. Adenosine triphosphate (ATP) is a likely candidate mediating 
activity-dependent recruitment of microglia [Fontainhas AM et al., 2011; Li Y et al., 2012]. 
ATP has been revealed as a clear “find me” signal, with surveillant microglia strongly 
attracted to the source of ATP, and activation toward a more phagocytic phenotype occurs 
via a signaling pathway involving P2Y purinoceptors [Davalos D et al., 2005; Koizumi S et 
al., 2007; Ohsawa K and Kohsaka S, 2011]. Glutamate has also been considered a 
potential candidate “find-me” signal mediating activity-dependent microglia migration, 
although its ability to attract microglia may only hold for a more activated phenotype 
[Fontainhas AM et al., 2011]. Once microglia are recruited to synapses via a “find-me” 
signal, one of the potential consequences can be phagocytosis in response to an “eat-me” 
signal. Several molecules with homology to the peripheral immune system have been 
shown to play some role in triggering phagocytosis of synapses. These include the major 
histocompatibility complex (MHC-1) and the complement cascade proteins, including C1q 
and C3 (Figure 8). Indeed, recent studies showed that the immune complement molecules 
C1q, C3 and the receptor CR3 (CD11b/CD18) are key molecules contributing to microglial 
phagocytosis of neurites and synapses [Stevens B et al., 2007; Schafer DP et al., 2012]. 
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C1q is the initiating protein of the classical complement cascade, which is part of the innate 
immune system. When C1q binds to and coats (opsonizes) synapses, it triggers a protease 
cascade which leads to the deposition of the downstream complement protein. 
Opsonization with activated C3 fragments (C3b and iC3b) leads to synapse pruning directly 
activating C3 receptors on macrophages or microglia, thereby triggering elimination by 
phagocytosis [Stevens B et al., 2007]. For instance, retinal ganglion cell (RGC) neurons 
express C1q, the upstream signalling molecule of C3, at P5 [Stevens B et al., 2007]. The 
receptor molecule for C3, CR3 is expressed in microglia [Schafer DP et al., 2012]. Genetic 
deletion of either the C3 ligand, or the CR3 receptor, reduced inclusions of presynaptic 
terminals in microglia, indicating a decreased microglial synapse phagocytosis [Schafer DP 
et al., 2012]. 
                    Postnatal Development          Healthy Adult Brain 
 
Figure 8. Microglia actively survey synapses and refine neuronal circuits in 
the healthy brain. During early postnatal development (left), microglia (illustrated 
in green) help refine excessive synaptic connections (illustrated in blue). Insert 
highlights microglial engulfment of synaptic elements. Microglia-related proteins 
including complement proteins and fractalkine have been suggested to mediate 
this process. In the healthy adult brain (right), microglial processes are dynamic 
and continuously survey surrounding synapses. (Adapted from: Soyon Hong et 
a., Current Opinion in Neurobiology 2016) 
 
 
Together, these findings indicate that microglia not only orchestrate brain inflammation (see 
1.2.4 - IL-1β, Microglia and Neuroinflammation) but also operate in the healthy brain, 
thus contributing to normal brain physiology. A role of microglia as immunological and non-
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immunological key player in brain thus emerges. While IL-1 primarily contributes to the 
microglia immunological role, it is still to be clarified whether and in which extent this 
cytokine also influences the non-immunological of microglia roles (Figure 9). 
 
Figure 9. IL-1 and microglial activation. Interleukin-1 activity and microglial 
activation may influence CNS pathogenesis via dysregulation of either their 
immunological or nonimmunological functions. (Adapted from: Xiaoyu Liu and 
Ning Quan – Frontiers in Neurology 2018) 
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AIM OF THE PROJECT  
 
 
 
 
 
The general aim of this project is to obtain a better understanding of how the 
proinflammatory molecule interleukin-1 beta (IL-1β) contributes to the physiological 
development of central neuronal circuits. Indeed, in the past decade or so, it has been 
shown the bidirectional communication between the central nervous system and the 
immune system in brain diseases, highlighting how immune molecules, such as the 
proinflammatory cytokine IL-1β, affect several brain functions participating in the pathogenic 
mechanisms of many neurological illnesses. There is now abundant evidence suggesting 
that IL-1β plays a detrimental role in hippocampal synaptic function [Avital A et al., 2003], 
and that the IL-1 type I receptor (IL-1RI) is essential for an efficient activation of microglia 
and the induction of multiple proinflammatory mediators in response to brain injury [Basu A 
et al., 2002]. Hence, the possibility that IL-1β may trigger some of the detrimental changes 
observed in certain neurodegenerative diseases is currently being assessed. However, 
despite most of these studies investigated the role of IL-1β in inflammatory-associated 
pathologies, its physiological role in synapse formation and function in the healthy brain is 
not completely known. Moreover, the finding that IL-1RI was highly expressed even in 
healthy states in the hippocampus, an area of the brain which plays a pivotal role in memory 
and learning, supports a possible physiological role for IL-1β in brain development and 
function.  
The aim of the project is to investigate the contribution of IL-1β to brain homeostasis 
using an IL-1R-/- mouse model, in order to clarify whether and how IL-1 signalling may alter 
the normal brain development and functionality. By taking advantage of this model, we will 
evaluate whether IL-1β signalling affects excitatory and inhibitory synaptic transmissions, 
mainly focusing on the hippocampal excitatory network. By western blot and 
immunofluorescence, we will first analyse the expression levels of both excitatory and 
inhibitory synaptic markers in brain homogenates and then, to assess whether possible 
changes in their expression have consequences on neurotransmission, we will perform 
electrophysiological recordings of post-synaptic currents in hippocampal neurons from 
acute brain slices from WT and knock-out mice. Golgi-staining of brain slices for the 
detection of dendritic spine density in hippocampal neurons will help in further assessing 
the role of IL-1 signaling in the formation and maintenance of the excitatory synapses during 
development. We will also analyse whether possible functional changes in the excitatory 
network result from neuron-autonomous processes or from an altered impact of non-
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neuronal cells on synapse development. To achieve this, we will characterize cell-specific 
properties in either neuronal or glial primary cultures established from WT and knock-out 
mice. With regards to neurons, we will analyse both expression levels of excitatory synaptic 
markers by western blot and strength of excitatory neurotransmission by patch-clamp 
recordings in hippocampal neuronal cultures. Given the importance of microglia cells in 
normal brain development, we will investigate the role played by IL-1 in shaping the function 
of these immune-resident brain cells by first evaluating possible changes in their functional 
state in both primary cultures and brain slices. Taking advantage of neurons-microglia co-
cultures, we will then further investigate the possible interplay between microglial cells, IL-
1β and synaptic contact refinement. Indeed, microglial cells are known to be the main key 
players in synaptic pruning. The subsequent elucidation of the molecular mechanism by 
which IL-1β alters synaptic transmission through the involvement of microglial cells will 
represent an important and emerging field of research in neuroscience. To finally assess 
whether possible altered enhanced excitatory neurotransmission and increased density of 
dendritic spines are associated to behavioural defects in knock-out mice, we will perform 
behavioural tests aimed to evaluate both cognitive and social capabilities.  
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MATERIAL AND METHODS 
 
 
 
 
 
Animals  
IL-1R knock-out C57BL/6 mice were obtained from Istituto Clinico Humanitas IRCCS, 
Milan, Italy. Primary hippocampal cultures were obtained from E17 embryos, while primary 
glial cultures were obtained from brains of neonatal mice (P0-P4). Tissues for WB analysis 
were taken from 9-day, 1-month and 7-month old male animals. For behavioural tests, 4-
month old male mice were used. Based on the evidence that gender-related differences, 
determined by genetic and hormonal influences, affect brain anatomy, function and 
behaviour, only male mice were used for experiments [Ngun TC et al., 2011; Jäncke L, 
2018; Choleris E et al., 2018]. No power calculations were done to estimate the adequate 
animal group size. All the experimental procedures followed the guidelines established by 
the European Legislation (Directive 2010/63/EU), and the Italian Legislation (L.D. no 
26/2014). 
  
Primary Cell Cultures 
Neuronal Cultures 
Mouse hippocampal neurons were obtained from the hippocampi of embryonic stage 
E17-18 fetal mice. The dissociated cells were plated onto 24 mm glass coverslips coated 
with poly-L-lysine at a density of 80,000 cells per coverslip. Cells were maintained in 
neuronal medium containing Neurobasal (Invitrogen, San Diego, CA) with 2% B27 
supplement, 1% antibiotic (penicillin-streptomycin), 1% glutamax, and incubated in a 
humidified at 37°C incubator supplemented with 5% CO2.  
Glial Cultures 
Glial cultures were prepared from the brains of 0-3-day old WT and IL-1R knock-out 
mice. Briefly, cells from whole brains were collected in glial medium containing Eagle’s 
Minimum Essential Medium (EMEM - Life Technologies) with 20% heat-inactivated fetal 
bovin serum (FBS, Sigma), 0.6% glucose, 1% penicillin-streptomycin 100X (10,000 units 
penicillin and 10 mg streptomycin/mL), 1% Na-pyruvate (100 mM), seeded into 75-cm2 
tissue culture flasks and grown at 37°C in a 5% CO2 humidified atmosphere. Secondary 
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pure microglial cultures were harvested from flasks of mixed glial cultures by shaking at 245 
revolutions per minute (r.p.m.) for 45 minutes 10-12 days after dissection. Cells were 
collected by centrifugation (800g for 10 min, RT), and plated in multiwells (150,000 cells per 
well in 12 well plates) coated with poly-ornithyne hydrobromyde (100 μg/ml). Cells were 
further cultured in EMEM supplemented with 20% FBS for 2 days before experiments. For 
microglia and neuron co-culture experiments, WT or knock-out microglia were added to 
mature hippocampal neurons (13-14 days in vitro) at a microglia to neuron ratio of 1:2 for 
24 hours. 
 
Electrophysiology  
Brain Slice Recordings 
To obtain acute hippocampal slices, IL-1R-/- and WT mice aged 26-30 days were 
deeply anesthetized as previously described and decapitated. Brains were removed and 
placed in ice-cold solution containing the following (in millimolar): 87 NaCl, 21 NaHCO3, 
1.25 NaH2PO4, 7 MgCl2, 0.5 CaCl2, 2.5 KCl, 25 D-glucose, and 7 sucrose, equilibrated with 
95% O2 and 5% CO2 (pH 7.4). Coronal slices (300 µm thick) were cut with a VT1000S 
vibratome from the hippocampus. Slices were incubated at RT for at least 1 h, in the same 
solution as above, before being transferred to the recording chamber. During experiments, 
slices were perfused at 2.0 mL/min with artificial cerebrospinal fluid (ACSF) containing the 
following (in millimolar): 135 NaCl, 21 NaHCO3, 1.6 CaCl2, 3 KCl, 1.25 NaH2PO4, 1.8 
MgSO4, and 10 D-glucose, aerated with 95% O2 and 5% CO2 (pH 7.4). Cells were examined 
with a BX51WI upright microscope (Olympus) equipped with a water immersion differential 
interference contrast (DIC) objective and an infrared (IR) camera (XM10r Olympus). 
Neurons were voltage clamped at a holding potential of -70 mV with a Multiclamp 700B 
patch-clamp amplifier (Molecular Devices, Union City, CA) at RT. Signals were amplified, 
sampled at 10 kHz, filtered to 2 or 3 KHz, recorded using the pClamp 10 data acquisition 
and analysed with either pClampfit 10 (Axon Instruments, Foster City, CA) or MiniAnalysis 
(Synaptosoft, Decatur, GA). Low-resistance micropipettes (2–3 MΩ) were pulled from 
borosilicate glass. Series resistance ranged from 10 to 20 MΩ and was monitored for 
consistency during recordings. Cells in culture with leak currents > 100 pA were excluded 
from the analysis. Miniature events smaller than 8 pA were not included in the analysis. 
Recordings of mEPSCs from hippocampal CA1 pyramidal neurons of WT and KO brain 
slices were always performed in the same experimental sessions. For miniature excitatory 
post-synaptic current (mEPSC) recordings, 1 µM tetrodotoxin (TTX), 20 µM bicuculline and 
50 µM amino-5-phosphonopentanoic acid (AP5) were added to the ACSF. Pipettes 
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contained (in millimolar): 135 K+-gluconate, 1 EGTA, 10 HEPES, 2 MgCl2, 4 Mg-ATP, and 
0.3 Tris-GTP (pH 7.4). Investigators were not blinded to the genotype of the mice during 
both electrophysiological recording and data analysis.  
Cell Culture Recordings  
Whole cell voltage-clamp recordings were performed on WT and transgenic 
embryonic hippocampal neurons maintained in culture for 13-15 DIV. During recordings, 
cells were bathed in a standard external solution containing (in mM): 125 NaCl, 5 KCl, 1.2 
MgSO4, 1.2 KH2PO4, 2 CaCl2, 6 glucose, and 25 HEPES-NaOH, pH 7.4. Recording pipettes 
(resistances of 3-5 MΩ) were filled with a standard intracellular solution containing (in mM): 
135 K+-gluconate, 1 EGTA, 10 HEPES, 2 MgCl2, 4 Mg-ATP and 0.3 Tris-GTP, (pH 7.4). For 
mEPSC recordings, 1 µM tetrodotoxin, 20 µM Bicuculline and 50 µM AP5 were added to 
the standard extracellular solution to block spontaneous action potential generation by 
GABA-A and NMDA receptors. Recordings were performed in voltage clamp mode at a 
holding potential of -70 mV using a Multiclamp 700B amplifier (Axon Instruments, Foster 
City, CA). Signals were amplified, sampled at 10 kHz, filtered to 2 or 3 KHz, recorded using 
the pClamp 10 data acquisition and analysed with either pClampfit 10 (Axon Instruments, 
Foster City, CA) or MiniAnalysis (Synaptosoft, Decatur, GA). Series resistance ranged from 
10 to 20 MΩ and was monitored for consistency during recordings. Cells in culture with leak 
currents > 100 pA were excluded from the analysis. Miniature events smaller than 8 pA 
were not included in the analysis. Electrophysiological mEPSC recordings from WT and KO 
neurons were always performed in the same experimental sessions. Investigators were not 
blinded to the genotype of the mouse cultures during both electrophysiological recording 
and data analysis. 
 
Immunofluorescent Staining on Free-Floating Sections  
Male mice were deeply anesthetized with intra-peritoneal injections of 
ketamine/xylazine (ketamine: 100 mg/kg; xylazine 10 mg/kg) and perfused intracardially 
with 4% paraformaldehyde (PFA). Immunofluorescent staining was carried out on free-
floating sections as described in [Menna et al., 2013]. Free-floating sections at the level of 
dorsal hippocampus were processed with specific primary antibodies at 4°C over-night, 
followed by incubation with the secondary antibodies for 2 hours at room temperature, 
counterstained with DAPI and mounted in Fluorsave (Calbiochem, San Diego, CA, USA). 
Sections were examined by means of an Olympus FV1000 confocal microscope (Olympus, 
Japan). Images were acquired in the stratum pyramidale or stratum radiatum of the CA1 
subfield of the hippocampus (as indicated) using a x40 oil immersion lens with additional 
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electronic zoom factor of up to 3, maintaining the parameters of acquisition (laser power, 
pinhole, gain, offset) constant among groups.  
 
Microglia Count and Morphological Analysis 
For microglial counts and morphologic analysis, confocal images for the selected 
marker Iba-1 were modified as 8-bit and Z-stack projection images. Iba-1 and DAPI+ cells 
were counted per HPF. The resulting images were smooth processed, binarized and 
skeletonized, using the Skeletonize Plugin for ImageJ [Arganda-Carreras I et al., 2010]. 
Before quantification, a mask using the particle analysis function was created to subtract 
from skeletonized images. The resulting images were processed by choosing the Analyze 
Skeleton 2D 3D option in the Skeletonize Plugin, and the number of branches and junctions 
per cell were obtained from the Results tables. 
 
Golgi Staining  
Mice (P60) were anesthetized and perfused intracardially as described above 
(immunofluorescent staining section). The brains were quickly but carefully removed and 
then transferred into individual Falcon tubes with Golgi-Cox solution and stored at room 
temperature in darkness for 6 days. After this period of impregnation, brains were moved to 
a sucrose solution (30%) for at least 2 days. Sectioning of the brains in a 6% sucrose 
solution followed. Coronal sections of 100 µm thickness were obtained using a vibratome 
(VT1000S, Leica, Wetzlar, Germany). These sections were placed onto gelatinated 
coverslips, washed in dH2O and processed with ammonium hydroxide for 30 min, followed 
by 10 min in Kodak Film Fixer, and were finally rinsed with distilled water, ethanol and xilene 
and finally mounted with a xylene-based medium. Spine density was estimated on branches 
of both apical and basal dendrites of pyramidal neurons located in the CA1 subfield of the 
hippocampus.  
 
Transfection and Dendritic Spine Analysis 
Mouse hippocampal neurons were transfected with GFP-plasmids using 
Lipofectamine 2000 (Invitrogen) 2-3 days before experiments or microscope image 
acquisition, at 11-12 days in vitro (DIV). Neurons were incubated with a pre-warmed DNA-
Lipofectamine solution in a humidified 37°C incubator supplemented with 5% CO2 for 30 
minutes. Cultures were analysed at DIV15 after fixation in 4% PFA and 4% sucrose for 10 
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minutes at RT. Images of primary hippocampal cultures were acquired with a 60× oil 
immersion lens (1,024 × 1,024 pixels) using a confocal microscope (FV1000 Olympus 
confocal microscope). GFP signal was acquired using an argon laser line, exciting at 488 
nm and collecting with a band-pass filter at 505-530 nm. Each image consisted of a stack 
of images taken through the z-plane of the cell. Confocal microscope parameters were kept 
constant for all scans in each experiment. Dendritic spine density was analysed using 
ImageJ software. For spine morphological analysis, spines were classified into the following 
categories: 1) Thin: spines with a long neck and a visible small head; 2) Mushroom: big 
spines with a well-defined neck and a very voluminous head.  
 
Western Blot Analysis 
Samples were collected in a lysis buffer either from primary cultures or tissue 
homogenates. Protein were resolved in 8-12% sodium dodecyl sulphate-polyacrylamide 
gels under reducing conditions. After over-night transfer onto polyvinylidene diflouride 
membranes at 80 mA, blots were blocked for 1 h at room temperature in a 5% milk or 5% 
BSA solution in Tris-buffered saline with 0.1% Tween-20 (TBS-T) at pH 7.4 and then 
incubated at 4°C overnight with primary antibodies diluted in 5% milk or 5% BSA TBS-T 
solution. Subsequently, membranes were washed and incubated for 1 h at room 
temperature in 5% milk or 5% BSA TBS-T solution with the secondary antibodies. Western 
blotting was performed by means of Chemi-Doc system + Image Lab software (Bio-Rad). 
Photographic development was by chemiluminescence (ECL, Amersham Bioscience or 
Immobilon substrate, Millipore). Western blot bands were quantified by the Image Lab 
software.  
 
Real-Time PCR 
Total RNA was extracted from WT and IL-1R-/- hippocampus using TRIzol (Invitrogen). 
1 μg RNA was reverse transcribed into first-strand cDNA using the High-Capacity cDNA 
Reverse Transcription Kit (Applied BiosystemsTM – Thermo Fisher Scientific, 
Massachusetts, USA) according to the manufacturer’s protocol. Quantitative PCR was 
performed using the TaqMan™ Fast Universal PCR Master Mix (2X) (Thermo Fisher 
Scientific). The following primers were used: 18s, AIF-1, TREM2, C1qA, C1qB, C1qC and 
TGF-β. All primer sets were purchased from Thermo Fisher Scientific. 
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ELISA Assay  
Concentrations of cytokines that are typically secreted by microglia (pro-inflammatory 
cytokines IL-6, IL-1β, TNF-α, and anti-inflammatory cytokines IL-10, IL-4) were assessed in 
the cell culture medium using ELISA kits (Peprotech) following manufacturers’ instructions. 
The absorption values were measured at a wavelength of 450 nm with a reference 
wavelength of 630 nm. Optical densities (OD) were plotted on a standard curve and 
expressed as pg/ml. 
 
Behaviour  
Self-Grooming  
WT and IL-1R knock-out mice were scored for spontaneous grooming behaviors as 
described earlier [Silverman JL et al., 2010] with slight modifications. Each mouse was 
placed individually into a clean mouse cage with a thin (0.5 cm) layer of bedding reducing 
neophobia, while preventing digging, a potentially competing behavior. After 5 minutes 
acclimatization, each mouse was scored with a stopwatch for 10 min for cumulative time 
spent grooming all body regions by the observer, who was not blinded to the genotype of 
the mice during the experimental procedure. 
Sociability and Social Recognition  
Sociability and social novelty tasks were performed on WT and IL-1R knock-out mice 
as previously described [Corradini I et al., 2014]. The apparatus consists of a 3-
compartment transparent polycarbonate box (20x40x22(h) cm each), with two sliding doors 
(5x8(h)cm), opening on the central compartment, that can be closed to confine the animal. 
The proband mouse was habituated in the central compartment for 5 min. For sociability 
assessment, an unfamiliar adult C57Bl/6 male mouse was placed in one side compartment 
whereas the opposite contained an empty wire cage. Immediately after the sociability task, 
the social novelty test was carried out in the same apparatus without any cleaning, placing 
a new unfamiliar mouse in the wire cage that had been empty during the prior 10-min 
session. Familiar and unfamiliar animals from different home cages had never been in 
physical contact with the subject mice or with each other. For both tests, the time spent in 
each chamber was recorded for 10 min. The observer was not blinded to the genotype of 
the mice during the experimental procedure. 
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Open Field  
General motor activity was tested in an open field task in WT and IL-1R-/- mice at 4 
months of age. Open field test was performed as previously described [Seibenhener ML 
and Wooten MC, 2015]. Videotracking-based methods (Ethovision, Noldus Systems, 
Leesburg, Virginia) were used during single 10-min trials to record the distance moved and 
time spent in the arena under dim lighting, along with a delineated ‘periphery zone’, a 
delineated ‘non-periphery zone’, and a delineated ‘centre zone’. General locomotion and 
anxiety-like behaviour parameters were then analysed and compared between WT and IL-
1R-/- mice. The observer was not blinded to the genotype of the mice during the 
experimental procedure. 
 
Novel Object Recognition 
A Novel Object Recognition (NOR) task was used to assess learning and long-term 
memory in WT and IL-1R-/- mice. Two identical objects were placed into the arena during a 
10 -minute sample phase. Subsequently, one of the objects was exchanged by a new object 
and memory was assessed by comparing the time spent exploring the novel object as 
compared with the time spent exploring the familiar object during a 10 -minute test phase 
[Leger M et al., 2013; Lueptow L, 2017]. The test was conducted in an open plastic arena 
(60x50x30 cm) in two phases. One week before the NOR experiments, the animals 
experienced handling by the experimenter and habituation to the arena for 5 and 2 
consecutive days, respectively (mouse handling reduces anxiety). During the first phase, 
lasting two days, mice were habituated to the test arena for 10 minutes. On the third day, 
mice were subjected to familiarization (T1) and novel object recognition (T2). During 
familiarization, two identical objects were placed in the arena. Each animal was placed in 
the centre of the arena, equidistant from the objects, and was left for a maximum of 10 
minutes, then it was returned to its home cage. 120 minutes later the mouse was introduced 
in the same arena with one of the two objects replaced with a new one for a maximum of 
10 minutes. Scoring was performed in the same manner as during familiarization. The 
objects used consisted of coloured plastic falcons and flasks. The arena and the objects 
were cleaned with 70% ethanol after each trial to remove olfactory cues. A discrimination 
index was calculated to evaluate the performance of each mouse as (Tn-Tf)/(Tn+Tf), where 
n = time spent exploring the object in the new location during T2, and f = time spent 
exploring the object in the familiar location during T2. Mice who did not move in the arena 
were excluded from the analysis. The observer was not blinded to the genotype of the mice 
during the experimental procedure. 
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Statistical Analysis 
Data are presented as mean ± standard error (SE) or as cumulative distribution from 
the indicated number of experiments. Statistical analysis and data graphing were performed 
using GraphPad PRISM 6 software (GraphPad, Software Inc., San Diego, CA, USA). After 
testing whether data were normally distributed or not, the appropriate statistical parametric 
or non-parametric test was used. The Kolmogorov–Smirnov test was used to determine 
significance in cumulative distributions of mEPSC amplitudes and some integrated density 
values. Differences between multiple groups were analysed by one-way ANOVA with a 
Bonferroni’s or Tukey’s post hoc test. Comparisons between two groups with a normal 
distribution were analysed using an unpaired t-test (two-tail distribution) or a Mann-Whitney 
test. Statistical analysis was performed using GraphPad Prism Software. The differences 
were considered to be significant if P≤0.05 and are indicated by (*); those at P≤0.01 are 
indicated by (**); those at P≤0.001 are indicated by (***); those at P ≤ 0.0001 by four (****). 
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RESULTS 
 
 
 
 
 
IL-1R–/– Mice Display Increased Synapse Density and Enhanced Excitatory 
Neurotransmission 
 
We used IL-1 receptor-deficient mice [Labow M et al., 1997; Glaccum MB et al., 1997] 
to examine the possible role of this cytokine in the development and function of 
glutamatergic synapses.  
To this aim, we firstly performed a morphological analysis of glutamatergic synaptic 
terminals through immunohistochemical analysis conducted at various stages of 
development (1-7 months), using antibodies against the vesicular glutamate transporter 1 
(VGlut1) (Figure 10B) and the postsynaptic density protein 95 (PSD95) (Figure 10D) in the 
CA1 hippocampal region (stratum radiatum). The analysis of confocal images revealed that 
IL-1R deficiency induces a significant increase of the immunepositive area of these 
excitatory synaptic markers in the CA1 hippocampal region, in both young (P30) and adult 
(7 months) knock-out mice (Figure 10C and 10E). These data indicate that the excitatory 
synaptic network is affected by IL-1 signalling perturbation.  
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Figure 10. Enhanced Immunostaining for the Excitatory Synaptic Markers 
VGlut1 and PSD95 in the Hippocampus of IL-1R–/– Mice. Representative fields 
(B and D) and relative quantification (C and E) of VGlut1 (B and C) and PSD95 
(D and E) immunostaining in the CA1 hippocampal region of WT and IL-1R-/- mice 
at different ages (1 month and 7 months). A shows a cartoon depicting 
hippocampal architecture; in red the stratum radiatum of CA1. Scale bar, 50 µm. 
**p < 0.01 ***p < 0.001, ****p < 0.0001, unpaired t test. For immunostaining: at 1 
month, WT N = 2 mice (n = 6 slices, n = 48 fields), IL-1R-/- N = 2 mice (n = 6 
slices, n = 56 fields); at 7 months, WT N = 2 mice (n = 6 slices, n = 53 fields), IL-
1R-/- N = 2 mice (n = 6 slices, n = 54 fields).   
 
 
To evaluate whether the increased staining of glutamatergic synaptic terminals was 
paralleled by higher expression levels of pre- and post-synaptic excitatory proteins, western 
blot analysis of the vesicular glutamate transporter VGlut1 and the post-synaptic density 
protein PSD95 was performed from brain lysates obtained from hippocampus and cortex of 
IL-1R-/- mice and WT at distinct stages of development (1-5-7 months) (Figure 11A and 
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11C). Variations of VGlut1 and PSD95 are expressed as a Fold Change, which is calculated 
by dividing the mutant value by the wild type value. We found a general increase in the 
expression levels of these synaptic proteins in both the hippocampus and cortex of IL-1R-/- 
mice, especially at 7 months of age (Figure 11B and 11D).  
 
Figure 11. Excitatory Synaptic Marker Expression Is Increased in IL-1R–/– 
Brains. Western blot analysis (A and C) and quantification (B and D) of PSD95 
and VGlut1 in the whole cortex (A and B) and hippocampus (C and D) of WT and 
IL-1R-/- mice at different ages (1 month, 5 months and 7 months). *p < 0.05, **p 
< 0.01, unpaired t test. For western blotting: at 1 month, WT N = 4 mice, IL-1R-/- 
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N = 4 mice; at 5 months WT N = 3 mice, IL-1R-/- N = 3 mice; at 7 months, WT N 
= 5 mice, IL-1R-/- N = 5 mice. 
 
 
To assess whether the higher expression of glutamatergic synaptic markers was paralleled 
by an enhancement in excitatory neurotransmission, whole-cell patch-clamp recordings of 
miniature excitatory postsynaptic currents (mEPSCs) (Figure 12C) were performed from 
the CA1 pyramidal neurons in acute hippocampal brain slices established from IL-1R-/- and 
control mice (P26-P30). Given the well-established role of IL-1β in cognition, we focused 
our electrophysiological characterization on CA1 hippocampal neurons because it has been 
reported that, within the hippocampal memory system, they are critically involved the 
formation, consolidation, and retrieval of hippocampal-dependent memories [Bartsch T et 
al., 2011]. In line with the histochemical data, both amplitude and frequency of mEPSCs 
were enhanced in the hippocampus of knock-out mice (Figure 12D and 12E). WT and 
knock-out hippocampal pyramidal neurons showed no differences in their passive 
membrane properties (membrane capacitance, Cm, and membrane resistance, Rm, Figure 
12A and 12B, respectively). This data confirms that the increased excitatory transmission 
observed in IL-1R-/- hippocampal pyramidal neurons depends on changes in synaptic 
activity rather than on alterations in the basic passive membrane properties of the neurons.   
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Figure 12. Glutamatergic Transmission is Increased in the Hippocampus of 
IL-1R–/– Mice. Passive membrane properties of WT and knock-out hippocampal 
pyramidal neurons are shown in A, membrane capacitance (Cm) and B, 
membrane resistance (Rm). Representative traces (C) of mEPSC recordings in 
CA1 pyramidal neurons from WT and IL-1R-/- hippocampi. Summary graph of 
mEPSC frequency (D) and amplitude (E). mEPSC frequency: *p < 0.05 **p < 
0.01, unpaired t test. Image scale bar 10 μm. Voltage traces: voltage scale bar, 
50 pA; time scale bar, 10 s. Membrane capacitance: WT 74.23 ± 8.49, n = 13 
cells; IL-1R-/- 68.64 ± 9.31, n= 11 cells. Membrane resistance: WT 87.85 ± 8.2, n 
= 13 cells; IL-1R-/- 87.55 ± 10.67, n = 11 cells. mEPSC frequency: WT 1.47 ± 
0.14, N = 4 mice (n = 14 cells); IL-1R-/- 1.96 ± 0.16, N = 4 mice (n = 13 cells). 
mEPSC amplitude: WT 12.34 ± 0.36; IL-1R-/- 15.07 ± 0.57. Data obtained with the 
contribution of Dr Raffaella Morini. 
 
 
In line with these data, analysis of spine density performed by Golgi staining (Figure 13A) 
in P60 CA1 pyramidal neurons revealed a significant increase in the number of dendritic 
protrusions/dendrite length in IL-1R-/- mice when compared to WT (Figure 13B and C). 
Given the evidence that the majority of excitatory synapses are formed on the surface of 
dendritic spines [Amaral MD and Pozzo-Miller L, 2009], all together these data indicate that 
the lack of IL-1 receptor results in an elevated number of glutamatergic synapses in the 
adult brain, thus suggesting a key role of the IL-1 signalling in regulating the formation or 
maintenance of excitatory network during brain development. 
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Figure 13. IL-1R–/– Mice Display Increased Dendritic Spine Density. 
Representative images (A) of hippocampus (upper panels) and secondary 
branches of dendrites (lower panels) of WT and IL-1R–/– CA1 neurons (P60) 
stained by the Golgi-Cox method and relative quantitation in apical (B) and basal 
(C) dendrites. Number of spines/mm: **p < 0.01, ****p < 0.001, unpaired t test. 
Scale bar, 250 µm; scale bar zoomed-in images, 25 µm. Apical dendritic spine 
density quantitation: WT 1.01 ± 0.04, N = 4 mice (n = 20 neurons); IL-1R-/- 1.24 ± 
0.06, N = 4 mice (n = 16 neurons). Basal dendritic spine density quantitation: WT 
0.9 ± 0.03, N = 4 mice (n = 20 neurons); IL-1R-/- 1.19 ± 0.06, N = 4 mice (n = 16 
neurons). Data obtained with the contribution of Dr Antonella Borreca. 
 
 
The structural and functional enhancement of the excitatory synaptic network observed in 
IL-1R-/- brain could result from the alteration of processes intrinsic to neuronal cells (neuron-
autonomous processes) or could result from an altered impact of non-neuronal cells on 
synapse development. In order to discriminate between these two possibilities, primary 
neuronal cultures were established from hippocampi of WT or IL-1R-/- embryos (E17). 
Mature primary hippocampal cultures (days in vitro 14, DIV14) are known to contain a 
moderate amount of astrocytes and to be completely devoid of microglia [Seibenhener ML 
and Wooten MW, 2012].  
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Previous works evaluated the relationship between age and maturity of a culture, as 
displayed by connections among neurons or spiking activity [Ben-Ari Y, 2001; Biffi E et al., 
2012]. Regardless of the tissue origin of the culture, at 7 Days In Vitro (DIV), neuronal 
cultures generally show a lower synaptic density and less neuronal cell connectivity with 
respect to older stages, with a peak at 14 DIV [Ichikawa M et al., 1993], which reflects the 
maturation of the network paralleled by that of the electrophysiological properties. Indeed, 
at 7 DIV the electrical activity is characterized by only single spikes whereas at 14 DIV 
networks exhibit an increase in firing rate, a rich and stable burst pattern (i.e. episodes of 
high frequency spiking) and highly synchronized periods of high frequency activity, 
encompassing simultaneously different network sites [Chiappalone M et al., 2006; 
Wagenaar DA et al., 2006]. Since DIV14 is considered a stage in culture where the level of 
neuronal maturation reflects the one that can be observed in-vivo in adult mice, we 
performed patch-clamp recordings on primary cultures of WT and knock-out DIV14 
hippocampal neurons (Figure 14C) revealed no changes in their passive membrane 
properties (membrane capacitance, Cm, and membrane resistance, Rm, Figure 14A and 
14B, respectively) and, interestingly, similar mEPSCs frequency and amplitude in the two 
groups (Figure 14D and 14E).  
 
Figure 14. IL-1R Deficiency Does Not Affect Neuronal Activity in Primary 
Cultures of Hippocampal Neurons. Passive membrane properties of WT and 
knock-out neurons are shown in A (membrane capacitance) and B (membrane 
resistance). Representative traces of mEPSCs (C) recorded from WT and IL-1R-
/- cultured hippocampal neurons in vitro (ad 14 days in vitro, DIV14) and 
quantification of frequency (D) and amplitude (E) of mEPSCs. Scale bars, 50 pA, 
10 s. Mann-Whitney unpaired t test. Membrane capacitance: WT 111.4 ± 5.27, n 
= 50 cells; IL-1R-/- 109.5 ± 3.36, n= 55 cells. Membrane resistance: WT 174.8 ± 
8.94, n = 50 cells; IL-1R-/- 175.1 ± 8.43, n = 55 cells. mEPSCs frequency: WT 
0.93 ± 0.11, n = 47 cells; IL-1R-/- 0.94 ± 0.11, n = 50 cells. mEPSCs amplitude: 
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WT 25.83 ± 1.29, n = 47 cells; IL-1R-/- 25.30 ± 1.25, n = 50 cells. Data obtained 
with the contribution of Dr Davide Pozzi. 
 
 
Consistently, western blot analysis of WT and IL-1R-/- cultured hippocampal neurons 
(Figure 15A) confirmed similar levels of expression of the excitatory synaptic markers 
PSD95 and VGlut1 at 14 days in vitro (DIV14) (Figure 15B and 15C).  
 
Figure 15. IL-1R Deficiency Does Not Affect Excitatory Synaptic Marker 
Expression in Primary Cultures of Hippocampal Neurons. Western blot 
analysis of primary WT and IL-1R-/- hippocampal neurons at DIV14 (A) and 
quantification of PSD95 (B) and VGlut1 (C) expression. Unpaired t test. Bar 
graphs represent mean ± SEM of 3 independent experiments. 
 
 
These data, revealing the absence of the synaptic phenotype in IL-1R-/- neurons when 
isolated from mice brain and grown in primary cultures, represent a strong indication that 
the enhanced development of the glutamatergic network is not an intrinsic feature of 
neurons, but instead a process that depends on the brain environment and that is likely to 
involve the participation of non-neuronal cells.  
 
 
IL-1R Deficiency Also Affects the Development of the Inhibitory Synaptic Network 
 
Having assessed that the genetic lack of IL-1 receptors results in the potentiation of 
excitatory neurotransmission, we aimed to evaluate whether its absence also impacts the 
development of the inhibitory network. To this aim we quantified the expression of the 
inhibitory pre-synaptic protein vesicular GABA transporter, VGAT, in the hippocampi of mice 
at 1 or 7 months of age (Figure 16A and 16B). Immunostaining of WT and IL-1R-/- brain 
slices for VGAT revealed an increase in the expression of this protein in the CA1 
hippocampal region (stratum radiatum) of 1-month-old knock-out mice (Figure 16C and 
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16D). However, a different result was observed in 7-month-old mice, where VGAT 
expression was slightly lower in knock-out mice relative to WT (Figure 16E and 16F). This 
result suggests the occurrence of age-dependent variations in the density of inhibitory 
GABAergic synapses in the hippocampi of IL-1R-/- mice.  
 
Figure 16. Age-Dependent Effects of IL-1R Deficiency on the Amount of 
Inhibitory Pre-Synaptic Terminals. Representative fields (A and B) and relative 
quantification (C, D, E and F) of the CA1 hippocampal region of WT and IL-1R-/- 
mice at 1 month (A) and 7 months (B) of age, immunostained for VGAT. Scale 
bar, 50 µm. Scale bar in zoomed-in images, 25 µm. *p < 0.05, unpaired t test. For 
immunostaining: at 1 month, WT N = 2 mice (n = 6 slices, n = 48 fields), IL-1R-/- 
N = 2 mice (n = 6 slices, n = 56 fields); at 7 months, WT N = 2 mice (n = 6 slices, 
n = 53 fields), IL-1R-/- N = 2 mice (n = 6 slices, n = 54 fields).   
 
 
At least 23 classes of GABAergic neurons have been described in the hippocampus. We 
decided to focus on the major subpopulation of GABAergic neurons, the parvalbumin-
immunopositive (PV+) cells, by immunofluorescence analysis (Figure 17A and 17B). We 
found that the number of PV-interneurons in the hippocampus of IL-1R-/- mice is higher at 1 
month but not at 7 months of age (Figure 17C and 17D) when compared to WT, consistent 
with the changes in the expression levels of VGAT. In particular, when comparing the 
parvalbumin-positive neurons distribution within each hippocampal sub-area (dentate gyrus 
DG, CA1, CA3) between WT and knock-out mice at 1 month of age (Figure 17G), we 
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observed that the increased number of these interneurons was statistically significant only 
in the CA1 region. Instead, their distribution did not differ between the hippocampal regions 
of 7-month old WT and knock-out mice (Figure 17H). This correlation between VGAT 
expression and the number of PV-interneurons may suggest that PV-interneurons are one 
of the subtypes of GABAergic neurons involved in the changes in VGAT expression. 
 
 
Figure 17. Age-Dependent Effects of IL-1R Deficiency on Parvalbumin 
Interneuron Density. Representative mosaic reconstruction (A and B) of WT 
and IL-1R-/- hippocampi labelled for parvalbumin (PV+)-interneurons from mice at 
1 month of age. Quantification (C and D) of parvalbumin-interneuron density in 
WT and IL-1R-/- hippocampi at 1 month (C) and 7 months (D). Confocal images 
showing parvalbumin-immunopositive (PV+) cells in the CA1 hippocampal region 
(E and F) of WT and IL-1R-/- mice at 1 month (E) and 7 months (F) of age and 
relative quantification (G and H) of parvalbumin interneurons distribution in the 
hippocampal regions (DG, CA1, CA3) at 1 month (G) and 7 months (H). Scale 
bar, 50 µm. **p < 0.01, ***p < 0.001, unpaired t test. For immunostaining: at 1 
month, WT N = 2 mice (n = 6 brain slices), IL-1R-/- N = 2 mice (n = 6 brain slices); 
at 7 months, WT N = 2 mice (n = 6 brain slices), IL-1R-/- N = 2 mice (n = 6 brain 
slices).  
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Identification of The Downstream Pathway Associated to The Increased Excitatory 
Synaptic Network 
 
Dendritic spines, highly specialized actin-based protrusions, are the primary site of 
excitatory synapses and are thought to function as the basic unit of synaptic integration 
[Yuste R and Denk W, 1995; Matus A et al., 2000; Bourne JN and Harris KM, 2008; Sheng 
M and Kim E, 2011]. Dendritic arborization and spine formation are critical for the functioning 
of neurons. Many proteins have recently been identified as regulators of dendritic 
morphogenesis, as well as several intracellular signaling pathways that control these 
processes. It is now well recognized the involvement of the phosphatidylinositol 3-kinase 
(PI3K)/Akt/mTOR and ERK pathways in the formation of functional excitatory synapses and 
in the control of synaptic plasticity [Sweatt JD, 2001; Kumar V et al., 2005; Howlett E et al., 
2008; Cohen-Matsliah SI et al., 2008; Lee CC et al., 2011; Silingardi D et al., 2011]. Based 
on this evidence and on the demonstration that the intracellular pathway associated with IL-
1R activation includes, among the other components, the Akt-mTOR pathway [reviewed in 
Riva F et al., 2012] and the phosphorylation of the extracellular signal–regulated kinases 
(ERK) [Kracht M and Saklatvala J, 2002; Fan Z et al., 2007] (Figure 18A), we focused our 
attention on these two pathways in order to identify the possible downstream signalling 
pathway associated to the increase in glutamatergic synapses found in the hippocampi of 
IL-1R-/- mice. Western blot analysis of pAKT and pERK in hippocampus homogenates 
obtained from 7-month old WT and knock-out mice (Figure 18B) revealed that the absence 
of IL-1R does not apparently affect any of these pathways (Figure 18C and 18D).  
 
 
Figure 18. IL-1R Effects on Excitatory Synapses In Vivo Do Not Seem to Be 
Mediated By AKT/ERK Pathways. Representation of the IL-1 intracellular 
signalling pathway (A). Western blot analysis (B) and quantification (C and D) of 
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pAKT and pERK expression in the hippocampus of 7-month old WT and IL-1R-/- 
mice. Unpaired t test. WT N = 5 mice, IL-1R-/- N = 5 mice. 
 
 
The recent demonstration that enhanced IL-1β signalling in the brain increases the 
expression level of MeCP2 in neurons, which negatively impacts synapse function, points 
to this factor as a potential molecular player linking inflammation and synaptic damage 
[Tomasoni R et al., 2017] (Figure 19A). To investigate whether IL-1R-/- mice show a change 
in MeCP2 level, Western blot analysis was employed to assess MeCP2 expression levels 
in the hippocampus of WT and knock-out mice at 1 month and 7 months of age (Figure 
19B). Consistent with the increase of the MeCP2 levels in response to enhanced IL-1β, we 
found a significant decrease of MeCP2 expression in knock-out mice relative to WT (Figure 
19C).   
 
Figure 19. Decreased MeCP2 Levels are Detectable in the Hippocampi of IL-
1R Deficient Mice. Schematic representation summarizing the functional effects 
that follow activation of IL-1 receptor induced by IL-1β, which regulates dendritic 
spine morphology by upregulating the transcription factor MeCP2 in an mTOR-
dependent manner [Tomasoni R et al., 2017] (A). Western blot analysis (B) and 
quantification (C) of MeCP2 expression in the hippocampus of WT and IL-1R-/- 
mice at 1 month and 7 months of age. *p < 0.05, unpaired t test. For western 
blotting: at 1 month, WT N = 4 mice, IL-1R-/- N = 4 mice; at 7 months, WT N = 5 
mice, IL-1R-/- N = 5 mice. 
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Given the statistically significant reduction in MeCP2 protein levels observed by western 
blot in knock-out mice at both 1 and 7 months of age, we decided to perform 
immunohistochemical analysis of MeCP2 expression in the CA1 region of 7-month old WT 
and IL-1R-/- mice (Figure 20B). We focused on 7 months of age because we assumed it 
could be a time point when possible compensatory mechanisms are already balanced. 
Brain slices were immunostained for NeuN, which is a specific marker that labels neuronal 
nuclei, in order to assess whether the MeCP2 reduction occurs specifically in neurons rather 
than in other brain cells. The quantification of the cumulative distributions of MeCP2 
integrated density values and the MeCP2 mean integrated density in neuronal cells in the 
two genotypes did not reveal any difference in knock-out versus WT neurons (Figure 20C 
and 20D). This result suggests the possibility that other brain cells other than neurons might 
be responsible for the reduced MeCP2 expression in IL-1R-/- brain tissue.  
  
Figure 20. Lack of Difference in the MeCP2 Expression Levels in Pyramidal 
Hippocampal Neurons of WT and IL-1R Deficient Mice. Representation of 
hippocampal regions (A); in red the stratum of CA1 pyramidal neurons. 
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Representative images of brain sections (CA1 hippocampus) of WT and IL-1R-/- 
mice (7 months old) stained for MeCP2 and DAPI, as indicated (B). Graphs show 
the cumulative distributions of MeCP2 integrated density values (C) and the 
MeCP2 mean integrated density in CA1 hippocampal neurons (D). Scale bar, 50 
µm. Number of analysed mice and neurons: WT N = 2 mice (n = 6 brain slices, n 
= 48 fields), hippocampal neurons = 483; IL-1R-/- N = 2 mice (n = 6 brain slices, 
n = 48 fields), hippocampal neurons = 494. Statistical comparison: unpaired t test 
for D and Kolmogorov-Smirnov test for C (D value 0.07740 with a corresponding 
p = 0.1072). 
 
 
Since it has been reported that the transcription factor MeCP2 is also important for microglial 
function, we investigated whether the reduced MeCP2 expression levels in KO brain was 
due to this cell type. To this aim, we performed MeCP2 immunocytochemical staining of 
microglia in the CA1 hippocampal region of 7-month old WT and IL-1R-/- mice (Figure 21A). 
Microglia were identified by the positive staining for CD39, a cell-surface ATPase highly 
expressed in this cell type [Braun N et al., 2000; Färber K et al., 2008; Matyash M et al., 
2017]. We found a significant decrease in MeCP2 immunopositivity in microglial cells of 
knock-out mice compared to WT (Figure 21B and 21C). A decrease of MeCP2 expression 
levels was also detectable by western blotting in cultured knock-out microglial cells (Figure 
21D), although not significant, suggesting that the phenotype could be maintained also in 
ex-vivo preparations (Figure 21E). 
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Figure 21. Decreased MeCP2 Levels in Hippocampal Microglia of IL-1R 
Deficient Mice. Representative images of brain sections (CA1 hippocampus) of 
WT and IL-1R-/- mice (7 months old) stained for MeCP2, CD39 and DAPI, as 
indicated (A). Graphs show quantitation of the MeCP2 mean integrated density 
(B) and the cumulative distributions of MeCP2 integrated density values (C) in 
CA1 hippocampal microglia. Western blot analysis (D) and quantification (E) of 
MeCP2 levels in WT and IL-1R-/- cultured microglia. ****p < 0.001, unpaired t test 
or Kolmogorov-Smirnov test. Scale bar, 10 µm.  Number of analysed mice and 
microglial cells (A-C): WT N = 2 mice (n = 6 brain slices, n= 30 fields), 
hippocampal microglia = 190; IL-1R-/- N = 2 mice (n = 6 brain slices, n= 30 fields), 
hippocampal microglia = 192. Statistical comparison: unpaired t test for B and E; 
Kolmogorov-Smirnov test for C (D value 0.2438 with a corresponding p < 0.0001). 
Bar graph represent mean ± SEM of 2 independent experiments (E). 
 
 
Lack of IL-1R Affects Microglia Number but not Microglia Morphology or Activation 
State During the Early Stages of Brain Development 
 
As the lack of IL-1 receptor in microglia cells is associated with lower MeCP2 levels, 
we hypothesized that the synaptic defects observed in knock-out mice could be ascribed to 
a specific microglial dysfunction. 
In order to assess whether IL-1R deficiency alters microglial phenotype, we first analysed 
the morphological features of microglia in IL-1R-/- and WT mice brain. Microglia density and 
morphology in the hippocampus was investigated at postnatal day 9 (P9), a timepoint critical 
for synaptic refinement [Paolicelli RC et al., 2011]. Microglia were identified through 
immunostaining with the myeloid cell marker ionized calcium-binding adapter molecule 1 
(Iba-1) (Figure 22A and 22B). A significant increase in microglial cell density was detected 
in the CA1 hippocampal region of IL-1R-/- brains compared to WT, a difference which was 
fully compensated in older mice (Figure 22C). Similar results were obtained in the 
somatosensory cortex of knock-out mice (Figure 22D). Interestingly, an increase in the 
number of VGlut1 positive puncta was observed in the hippocampus of IL-1R-/- mice at the 
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same developmental stage (postnatal day 9) where the temporary higher microglia density 
was observed (Figure 22E-G). 
 
Figure 22. IL-1R Deficiency Affects Microglia Number During the Early 
Stages of Brain Development. Confocal images of CA1 hippocampal and 
cortical microglia labelled for Iba-1 in brain slices obtained from WT or IL-1R-/- 
mice at postnatal day 9 (P9) (scale bar, 50 µm) (A and B). Quantification of 
microglia density (number of Iba-1+ cells per field) in the CA1 hippocampal region 
(C) and somatosensory cortex (D) of WT and knock-out brain at different ages 
(P9, 1 month, 7 months). Representative fields (F) and relative quantification (G) 
of VGlut1 fluorescent signal in the CA1 hippocampal region (E, representation of 
hippocampal regions; in red the stratum radiatum of CA1) of P9 WT and IL-1R-/- 
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brain. Scale bar, 50µm. **p < 0.01, ***p < 0.001, unpaired t test.  For microglia 
count: at 9 days WT N = 2 mice (n = 4 brain slices, n = 24 hippocampal fields, n 
= 12 cortical fields), IL-1R-/- N = 2 mice (n = 4 brain slices, n = 24 hippocampal 
fields, n = 12 cortical fields); at 1 month WT N = 2 mice (n = 4 brain slices, n = 24 
hippocampal fields, n = 12 cortical fields), IL-1R-/- N = 2 mice (n = 4 brain slices, 
n = 24 hippocampal fields, n = 12 cortical fields); at 7 months WT N = 2 mice (n 
= 4 brain slices, n = 24 fields), IL-1R-/- N = 2 mice (n = 4 brain slices, n = 24 
hippocampal fields, n = 12 cortical fields). For VGlut1 immunostaining at 9 days: 
WT N = 2 mice (n = 6 brain slices, n = 57 fields), IL-1R-/- N = 2 mice (n = 6 brain 
slices, n = 45 fields). 
 
 
It is known that microglia morphology and function are closely related. For instance, under 
basal healthy conditions, a resting phenotype characterized by a ramified morphology 
predominates. These microglia are not actually resting but continuously scanning their 
environment [Nimmerjahn A et al., 2005; Olah M et al., 2011], pruning synapses and 
regulating neuronal activity, providing a “fine-tuning” of neural circuits [Paolicelli RC et al., 
2011; Schafer DP et al., 2012; Miyamoto A et al., 2013] and neurotransmitter 
signaling/synaptic transmission [Li Y et al., 2012; Béchade C et al., 2013; Domercq M et al., 
2013]. However, in situations of neuroinflammation or after injury, ramified microglia can 
transform into an “activated state”, characterized by swollen ramified cells with a larger cell 
body and shorter, thick processes [Davis EJ et al., 1994; Fernández-Arjona MDM et al., 
2017]. 
To evaluate whether IL-1 deficiency affects microglial morphology, we immunostained brain 
slices obtained from WT and KO mice for the microglial marker Iba1 and confocal images 
were processed with a morphological skeleton analysis. The morphological analysis of Iba1-
positive cells in the hippocampi of P9 mice (Figure 23A and 23B) did not reveal any 
difference in the ramified phenotype for either genotype (Figure 23D). Furthermore, the 
average size of the soma, the average length of the branches and the number of branches 
per cell did not differ between knock-out and WT microglial cells (Figure 23C and 23D). 
These data show that, in IL-1R-/- hippocampi, microglia cells are temporarily augmented in 
number although their morphology does not appear to be different. This may be consistent 
with the possibility that their activation state is not affected. In line with this result, knock-
out cultured microglia did not differ in the expression or release of anti- and pro-inflammatory 
cytokines, as assessed by ELISA (Figure 23E), supporting the hypothesis that the 
deficiency of IL-1R does not affect microglia activation. 
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Figure 23. IL-1R Deficiency Does Not Affect Microglia Morphology and 
Activation During the Early Stages of Brain Development. Confocal images 
of CA1 hippocampal microglia labelled for Iba-1 in brain slices obtained from P9 
WT or IL-1R-/- mice (A and B). Skeletonized reconstruction (A and B) and 
quantitative analysis of soma size (C), total branches per cell and average branch 
length (D) in Iba-1+ cells in the CA1 stratum radiatum. Quantification of IL-1β, IL-
6, TNF-α, IL-10 and IL-4 release in the medium of cultured microglia by ELISA 
(E) did not show difference in the production of nor pro-inflammatory neither anti-
inflammatory cytokines between WT and KO microglial cells. Scale bar, 50 µm. 
For skeletonize analysis (A-D): WT N = 2 mice (n = 4 brain slices, n = 24 
hippocampal fields), IL-1R-/- N = 2 mice (n = 4 brain slices, n = 24 hippocampal 
fields). Bar graph represent mean ± SEM of 3 independent experiments (E). 
Unpaired t test. 
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Lack of Microglial IL-1 Receptor Results in Defective Synapse Elimination In Vitro 
 
Our evidence, indicating that the synaptic phenotype of IL-1R-/- neurons is not a cell-
autonomous process, together with the changes in number and MeCP2 expression 
detected in microglia of IL-1R-/- mice, open the possibility that the overall increase of the 
excitatory synapses observed in IL-1R-/- mice might be due to a possible deficit in microglia 
function. In particular, we hypothesized that knock-out microglia may be defective in the 
process of synaptic pruning, which would lead to long-term effects on synapse refinement. 
To test whether IL-1signaling in microglia contributes to this process, WT hippocampal 
neurons were co-cultured with either WT or IL-1R-/- microglial cells (Figure 24A), and the 
dendritic spine density was analysed in both conditions (Figure 24B). Consistent with the 
ability of microglia to phagocytose synapses [Ji K et al., 2013; Lui H et al., 2016; Filipello F, 
Morini R et al., 2018], neurons co-cultured with WT microglia for 24 hours displayed a 
significant reduction of dendritic spine density (Figure 24C), as indicated by the reduction 
of mushroom spine (Figure 24D) and show a trend for thin spine density (Figure 24E). On 
the contrary, neurons cultured in the presence of IL-1R-/- microglia did show a smaller 
reduction of total dendritic spine density (Figure 24C). Interestingly, microglia lacking IL-1 
receptor seem to partially fail to remove spines, especially mature mushroom spines 
(Figure 24D), indicating impaired synapse elimination. Although a direct demonstration of 
lower levels of synaptic markers in phagocytic organelles of IL-1R-/- microglia in vitro and in 
vivo [Filipello F, Morini R et al., 2018] is still required, these data suggest that the lack of 
the cytokine receptor in microglia impairs the synaptic pruning process.  
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Figure 24. Lack of Microglial IL-1 Receptor affects Spine Elimination In 
Vitro. Confocal images representative of hippocampal neurons co-cultured with 
either WT or IL-1R-/- microglia (A) and of spine density and morphology in each 
condition (scale bar, 10 µm) (B). Quantification of total dendritic spine (C), 
mushroom spine (D) and thin spine density (E) under the conditions described 
above. Scale bar, 50 µm; scale bar zoomed-in images, 10 µm. ****/#### p < 0.0001, 
One-way ANOVA followed by Dunn’s multiple comparison test.  vs  : #;   
vs  : *. Bar graph represent mean ± SEM of 2 independent experiments. 
Number of total spines/ branch length: hippocampal neurons (HN) (n = 30 
neurons) 0.59 ± 0.02; HN + WT microglia (n = 32 neurons) 0.38 ± 0.01; HN + IL-
1R-/- microglia (n = 40 neurons) 0.49 ± 0.01. Number of mushroom spines/branch 
length: hippocampal neurons (HN) (n = 30 neurons) 0.27 ± 0.02; HN + WT 
microglia (n = 32 neurons) 0.13 ± 0.01; HN + IL-1R-/- microglia (n = 40 neurons) 
0.23 ± 0.01. Number of thin spines/branch length: hippocampal neurons (HN) (n 
= 30 neurons) 0.32 ± 0.02; HN + WT microglia (n = 32 neurons) 0.26 ± 0.01; HN 
+ IL-1R-/- microglia (n = 40 neurons) 0.27 ± 0.01. 
 
 
Our group has recently shown that an immune protein, the triggering receptor expressed 
on myeloid cells 2 (TREM2), is essential for microglia-mediated synaptic refinement during 
early stages of brain development [Filipello F, Morini R et al., 2018]. Hence, we investigated 
whether this pathway was involved in the deficient synaptic pruning observed in IL-1R-/- 
microglia. Confocal analysis of immunostained brain slices obtained from P9 WT and IL-
1R-/- mice (Figure 25A and 25B) did not show differences in microglial TREM2 expression 
(Figure 25C-G). Also, the expression of CD68, a macrophage-specific phagolysosomal 
marker, did not differ between the two microglial subpopulations (Figure 25D-H).  
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Figure 25. IL-1R Deficiency Does Not Affect Microglia Expression of TREM2 
and CD68. Confocal images of CA1 hippocampal microglia (A and B) labelled 
for Iba-1, CD-68 ad TREM2 in brain slices obtained from P9 WT or IL-1R-/- mice. 
Representative 3D reconstruction of TREM2 and CD-68 puncta within microglial 
cell (A). Graphs show cumulative distribution of integrate density values and 
mean integrated density values for TREM2 puncta (C and E) and CD68 puncta 
(D and F), and number of TREM2 puncta (G) or CD68 puncta (H) per microglial 
cell. Scale bar, 50 µm; scale bar zoomed-in images, 10 µm. WT N = 2 mice (n = 
6 brain slices, n = 24 fields); IL-1R-/- N = 2 mice (n = 6 brain slices, n = 24 fields). 
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Statistical comparison: unpaired t test for E-H and Kolmogorov-Smirnov test for 
C and D. 
 
 
Since it has already been reported that TREM2 protein is developmentally regulated in a 
region- and age-dependent manner in the mouse postnatal brain, we wanted to investigate 
its expression at a different and later time point [Chertoff M et al., 2013]. We quantified 
TREM2 mRNA levels in the hippocampi of P19 WT and IL-1R-/- mice by real time PCR and 
we observed that its mRNA levels did not differ between the two groups (Figure 26), in line 
with our immunohistochemical analysis at P9.  
However, elimination of abnormal synapses during development might occur though 
different pathways. For instance, fractalkine (CX3CL1)/CX3CR1 and the classical 
complement systems are considered mediators of microglia interactions with synapses 
[Paolicelli RC et al., 2011]. In particular, the classical complement proteins C1q and C3 
localize to the synapse and mediate synapse elimination by microglia during brain 
development [Stevens B et al., 2007; Stephan AH et al., 2012].  
We therefore evaluated the mRNA levels of C1q subunits (C1qA, C1qB and C1qC) to 
uncover a possible defective expression of these classical complement cascade proteins. 
The glia-derived transforming growth factor β (TGF-β), which is known to regulate neuronal 
C1q expression and developmental synaptic refinement [Bialas AR and Stevens B, 2013], 
was used as internal control for C1q subunits. We found a strong decrease in the mRNA 
levels of each C1q subunit and TGF-β in the hippocampus of KO mice at P19 when 
compared to WT controls (Figure 26). These results indicate that mice lacking IL-1 receptor 
have normal TREM2 levels but reduced C1q expression in the hippocampus, suggesting 
an indirect implication of IL-1R in regulating neuronal C1q expression to initiate 
complement- and microglia-mediated synaptic pruning. 
 
Figure 26. IL-1R–/– Mice Display Defective Expression of Classical 
Complement Protein C1q. Real Time PCR (RT PCR) performed in the 
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hippocampus of P19 WT and IL-1R-/- mice. The analysis revealed a significant 
decrease in mRNA levels of C1q subunits and TGF-β in KO hippocampi. TREM2 
mRNA levels were normalized to Iba-1 and 18s; TGF-β and C1q subunits mRNA 
levels were normalized to GAPDH. WT N = 3 mice, IL-1R-/- N = 4 mice. *p < 0.05, 
***p < 0.001, unpaired t test. 
 
 
IL-1R–/– Mice Display Altered Behavioural Phenotype 
 
Despite the heterogeneity of the diseases in which IL-1β is involved, a growing body 
of evidence points toward cognition as a shared physiological process hit by the cytokine. 
It is now clear that an alteration of the physiological process of neuronal network refinement 
via synaptic pruning can directly affect social and cognitive behaviour [Zhan Y et al., 2014; 
Paolicelli RC et al., 2014; Paolicelli RC and Ferretti MT, 2017; Filipello F, Morini R et al., 
2018; Calcagno N et al., 2018]. Based on this evidence, we investigated whether IL-1R-/- 
mice (P60) display an altered behavioural phenotype.  
The Open Field (OF) test provides a variety of behavioural information ranging from general 
ambulatory ability to data regarding the emotionality of the animal [Wilson RC et al., 1976; 
Seibenhener ML and Wooten MC, 2015]. Normally, mice seek the protection of the 
periphery rather than the vulnerability of the centre. Mice that are less anxious are expected 
to spend more time in the centre, while mice that show signs of motor deficits are expected 
to cover lower horizontal distances and vertical movements [Ojha J et al., 2011]. Based on 
this, we tested 4-month-old (4mo) WT and KO mice in an open area and several activities 
were monitored. To assess locomotor ability, we analysed: (I) counts of ambulatory 
(walking), stereotypic (repetitive activity, e.g. grooming) and vertical (rearing up) 
movements; (II) total ambulatory distance travelled; (III) ambulatory velocity (Figure 27B). 
Anxiogenic behaviour was assessed measuring some of these parameters comparing 
centre versus periphery (Figure 27C). General locomotor activity was not significantly 
altered in 4mo KO versus WT mice (Figure 27B). Environment exploration was not affected 
in these KO mice (Figure 27B). Furthermore, no differences were observed in anxiety-
related motor paradigms, as shown by comparable time spent in the corners of the arena 
or close to the walls (Figure 27C). These data suggest that IL-1R-/- mice have no alteration 
in motor coordination and anxiety related behaviours. 
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Figure 27. IL-1R–/– Mice Do Not Display Altered Anxiety-like Behavior or 
Impairments in General Locomotor Activity. Schematic representation of 
Open Field (OF) test performed in 4-month old WT and IL-1R-/- mice (CZ, central 
zone; PZ, peripheral zone) (A). Comparison of general locomotion (B) and 
anxiety-like behaviour (C) parameters did not reveal any difference between WT 
and IL-1R-/- mice. Unpaired t test not significant. WT N = 8 mice, IL-1R-/- N = 8 
mice. Data obtained with the collaboration of Dr Patricia Marcal Alves Correia. 
 
 
To assess cognitive functions, WT and IL-1R-/- mice were tested using the Novel Object 
Recognition (NOR) task (Figure 28A), which is based on the spontaneous tendency of mice 
to spend more time exploring a novel object than a familiar one. This test normally relies on 
three sessions: one habituation session, one training session, and one test session. 
Training involves visual exploration of two identical objects, while the test session involves 
replacing one of the previously explored objects with a novel one. The choice to explore the 
novel object reflects the use of learning and recognition memory. The time between training 
and testing can be altered to assess any changes in short- and long- term memory. It has 
been shown that the right hippocampus is active during the delay interval of a short-term 
memory task specifically when associations between an object and its location have to be 
held online. These findings confirm and extend recent human lesion evidence [Olson IR et 
al., 2006] by showing that the spatial association held online specifically drives hippocampal 
contribution to short-term memory maintenance [Piekema C et al., 2006]. For this reason, 
we decided to investigate performances linked to short-term memory in WT and KO mice 
64 | P a g .  
 
in a novel object recognition paradigm. Results for this test were expressed as a 
discrimination index (DI) between objects during the test session, calculated as the 
difference between the time spent exploring the novel object (Tn) and the familiar object 
(Tf) divided by the total time exploring both objects (DI = (Tn–Tf)/(Tn+Tf)). The analysis 
revealed that 4-month old IL-1R-/- mice do not display defects in the Novel Object 
Recognition task when compared to WT (Figure 28B).  
 
Figure 28. IL-1R–/– Mice Do Not Display Impairments in a Memory Task 
Paradigm. Novel Object Recognition (NOR) task performed in 4-month old WT 
and IL-1R-/- mice (A). The discrimination index calculated to evaluate the 
performance of each mouse did not reveal any defects in the memory task 
between WT and KO mice (B). p = 0.4334, unpaired t test not significant. WT 
0.18 ± 0.09 N = 8 mice, IL-1R-/- 0.28 ± 0.09 N = 8 mice. Data obtained with the 
collaboration of Dr Patricia Marcal Alves Correia. 
 
 
Of note, and consistent with the evidence that defects in synapse phagocytosis during 
development are associated with social behavioural defects typical of autism spectrum 
disorder (ASD) [Filipello F, Morini R et al., 2018; Calcagno N et al., 2018], several 
impairments of social behaviour were detected in IL-1R-/- mice. Indeed, by using a sociability 
test (Figure 29A), we found that in contrast to WT mice, which spent longer time exploring 
the chamber with a stranger mouse than the empty compartment, IL-1R-/- mice spent a 
comparable amount of time in the two chambers (Figure 29B). No defects were detected 
in the social recognition task (Figure 29A), where IL-1R-/- mice performed similarly to 
controls (Figure 29C). These data suggest that IL-1R-/- mice show significant deficits in 
social behaviour but not in memory recognition tasks. Furthermore, these mice displayed a 
strong increase in self-grooming behaviour (Figure 29D), a measure of repetitive behaviour 
typically associated with autism spectrum disorder [McFarlane HG et al., 2008]. Altogether, 
these data indicate that lack of IL-1 receptor expression during development leads to 
behavioural defects reminiscent of ASD.  
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Figure 29. IL-1R–/– Mice Display Impairments in Repetitive and Social 
Behaviors. Schematic representation of Sociability and social novelty test (A). 
Sociability test (B) performed in a social choice paradigm, social memory test (C) 
performed in a social novelty paradigm and self-grooming test (D) in P60 WT and 
IL-1R-/- mice. *p < 0.05, unpaired t test. WT N = 8 mice, IL-1R-/- N = 8 mice. Data 
obtained with the collaboration of Dr Antonella Borreca. 
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DISCUSSION 
 
 
 
 
 
Inflammation is increasingly recognized as a key factor influencing many neurological 
disorders occurring in adulthood, when brain development is completed [Skaper SD et al., 
2018]. However, a growing body of evidence is now highlighting a central role played by 
inflammation at early stages of neuronal development, even at prenatal stages, when the 
immature brain, upon exposure to viral or bacterial infective agents, may undergo an 
inflammatory-mediated alteration of development [Hagberg H et al., 2015]. Indeed, 
extensive research is providing evidence that inflammation has long-term consequences on 
physiological brain development and could speculatively affect the risk and/or severity of a 
variety of brain diseases, including autism spectrum disorders (ASDs), schizophrenia, and 
intellectual disabilities (IDs), which represent recognized synaptopathies [Fan X et al., 
2007; Dantzer R et al., 2008; Najjar S et al., 2013]. Pro-inflammatory cytokines, including 
interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumour necrosis factor alpha (TNF-α), appear 
to be at the forefront in the communication between the immune and the nervous system, 
playing dual roles in either mediating physiological and neuroprotective roles in normal brain 
function [Parish CL et al., 2002; Nakanishi M et al., 2007; Heese K, 2017] or being 
detrimental and associated with brain diseases, especially when present at elevated 
concentrations [Ashwood P et al., 2011; Suzuki K et al., 2011; Wei H et al., 2011; Erta M et 
al., 2012; Chase KA et al., 2016; O’Keeffe GW, 2017].   
IL-1β has been one of the most studied cytokines involved in both pathological and 
non-pathological processes in the CNS. Several recent studies have addressed some of 
the issues relating to the role of IL-1β in the brain, specifically in the hippocampus, under 
pathological conditions, and showed a detrimental role of the cytokine in processes such 
as neural plasticity and memory [Katsuki H et al., 1990; Bellinger FP et al., 1993; Ross FM 
et al., 2003; Goshen I et al., 2007; Barrientos R et al., 2002; Hein AM et al., 2010]. 
Conversely, IL-1β physiological role in synapse formation and function in the healthy brain 
is not completely known. Few recent evidences suggest that, at least under some 
circumstances, IL-1 may actually be required for a physiological regulation of hippocampal 
plasticity and learning processes. As a support to this possibility, IL-1 expression in the 
hippocampus is substantially increased during LTP, both in vitro and in vivo, while blocking 
IL-1 receptors with IL-1Ra (the interleukin-1 receptor antagonist) impairs the maintenance 
of LTP [Schneider H et al., 1998; Coogan AN and O'Connor JJ, 1999]. Moreover, IL-1Ra 
also reduces memory in the water maze and passive avoidance paradigms, whereas IL-1β 
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administration facilitates memory in the passive avoidance test [Yirmiya R et al., 2002]. 
Together, these data seem to indicate that the effects of the cytokine can be described by 
a typical U-shaped curve, with optimal cytokine concentration being required for allowing 
the occurrence of physiological processes, and “too low” or “too high” concentrations 
leading to neuronal dysfunctions. 
IL-1 receptor type I knockout (IL-1R KO) mice were previously used to evaluate the 
implication of IL-1 signalling pathways in the physiological mechanisms underlying learning, 
memory, and neural plasticity. IL-1R KO mice were found to exhibit enhanced paired-pulse 
inhibition in response to perforant path stimulation and no LTP in the dentate gyrus. 
Moreover, decreased paired-pulse responses, as well as a complete absence of LTP, were 
observed in vitro in the CA1 region of hippocampal slices taken from IL-1R KO mice 
compared to WT controls [Avital A et al., 2003]. These results suggest that IL-1 contributes 
to the regulation of memory processes as well as short- and long-term plasticity within the 
hippocampus. These ﬁndings have important implications for several conditions in humans, 
which are associated with long-term defects in IL-1 signaling, such as mutations in the IL-1 
receptor accessory protein-like gene, which are involved in a frequent form of X-linked 
mental retardation [Avital A et al., 2003]. Despite this evidence, the underlying molecular 
mechanisms are still unknown.  
 
Lack of IL-1 Signaling Leads to a General Enhancement of The Excitatory 
Neurotransmission And an Increase in Dendritic Spines Density 
Our study aimed to clarify how IL-1β contributes to brain homeostasis and to identify 
the process by which the lack of the IL-1 signaling may alter learning and memory 
processes. It has already been reported that IL-1 signaling affects neuronal synaptic activity 
by regulating synaptic scaffolding protein levels in the hippocampus. In particular, it was 
found that the absence of IL-1 receptor increases the expression of both the excitatory 
scaffolding protein postsynaptic density-95 (PSD95) and the inhibitory scaffolding protein 
gephyrin in the hippocampus of IL-1R deficient mice [Avdic U et al., 2015]. In line with these 
findings, we found that mice genetically devoid of IL-1R show an abnormal enhancement 
of excitatory transmission. Through western blot of brain homogenates and 
immunofluorescence analysis of sections from young or adult IL-1R KO and WT mice we 
indeed observed an increased expression of excitatory pre- and post-synaptic markers 
(VGlut1 and PSD95, respectively) in the KO mice, which is maintained throughout the entire 
life span of mice. Consistently, electrophysiological recordings of hippocampal CA1 
pyramidal neurons highlighted a significant increase in the frequency and amplitude of 
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excitatory miniature post-synaptic currents, pointing towards a potentiation of the excitatory 
network. A further confirmation of the structural potentiation of the excitatory network in IL-
1R KO mice was obtained by the analysis of Golgi-stained brain slices of KO mice, which 
showed a significant increase in spine density in both apical and basal dendrites of CA1 
hippocampal neurons.  
Avdic and colleagues previously showed an increased expression of the inhibitory 
scaffolding protein gephyrin in the hippocampus of IL-1R-/- mice at 4-5 months of age. 
However, when we immunostained brain slices obtained from young (1 month) and adult (7 
months) WT and KO mice for the inhibitory pre-synaptic marker VGAT, we observed 
opposite results at the two different time points examined. While VGAT expression resulted 
significantly increased in the CA1 hippocampal region of 1-month old KO brain when 
compared to WT, no differences were detectable in older mice. Different alterations of 
excitatory and inhibitory transmission seem therefore to occur in the hippocampus of knock-
out mice at distinct ages, with specific age-dependent impacts to the excitatory/inhibitory 
balance. In young KO mice, we found a general potentiation of both excitatory and inhibitory 
transmission, possibly suggesting a transient compensatory elevation of inhibitory 
transmission aimed at controlling the increase in the excitatory transmission, which is 
instead long-lasting, in order to restore balance and maintain network homeostasis. Similar 
compensatory processes, including homeostatic plasticity mechanisms, have been 
previously described in a variety of invertebrate [Davis GW, 2006; Marder E and Goaillard 
JM, 2006] and vertebrate [Pozo K and Goda Y, 2010; Turrigiano G, 2011; Turrigiano GG 
and Nelson SB, 2004] model systems. However, in older mice, the selective increase of 
excitatory neurotransmission results in alterations of the excitatory/inhibitory (E/I) balance 
which favours excitation. In the adulthood, the inhibitory neurotransmission fails in balancing 
the excess of excitation and this fact opens the possibility that different processes may be 
at the basis of the synaptic potentiation occurring at the two stages. The effects of IL-1R 
lack on excitatory and inhibitory networks and their important implications on the E/I 
balance, which is known to be crucial for preserving circuit function, may be responsible for 
the behavioural deficits observed in IL-1R deficient mice. Indeed, it is now recognized that 
excitation/inhibition imbalance is implicated in neuropsychiatric disorders (autism spectrum 
disorders, schizophrenia, epilepsy) [Fritschy JM, 2008; Žiburkus J et al., 2013; Gao R and 
Penzes P, 2015; Nelson SB and Valakh V, 2015; Lee E et al., 2017; Selten M et al., 2018].  
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(Modified from: Inferring synaptic excitation/inhibition balance from field potentials - 
Gao R et al., Neuroimage 2017) 
 
 
Neuronal network function depends markedly on the inhibitory system mediated by 
GABAergic interneurons. These cells form a wide and heterogeneous population which can 
be classified into several cell types, based on physiological properties, neurochemical 
marker content, somatodendritic location and most notably, location of their axon terminals 
[Freund TF and Buzàki G, 1996]. Among the various interneuron types, perisomatic 
inhibitory interneurons (PIIs) have attracted greatest attention because they comprise one 
of the largest interneuron sub-population in cortical circuits [Freund TF and Buzàki G, 1996]. 
Although PIIs show deﬁned morphological properties, they can also be classiﬁed on the 
basis of their neurochemical content into two major types, the parvalbumin (PV)- and the 
cholecystokinin (CCK)-expressing PIIs. In particular, PV+ basket cells form synapses on 
the cell body and axonal initial segment of pyramidal cells, regulating their output and 
coordinating the activity of neuronal assemblies. Changes in their number may have 
therefore severe functional consequences. For example, it is known that a hallmark of the 
pathology of schizophrenia is an alteration of the GABAergic system in prefrontal cortex 
(PFC) [Lewis DA et al., 2005] and hippocampus [Zhang ZJ and Reynolds GP, 2002], and 
that the loss of hippocampal interneurons, by shifting the excitation-inhibition balance, may 
be at the basis of the onset of temporal lobe epilepsy (TLE) [Sayin U et al. 2003; Wyeth MS 
et al. 2010]. Alterations in the number and/or function of parvalbumin-expressing (PV+) 
GABAergic interneurons in the cortex and in the hippocampus may therefore result in 
dysfunctions typical of different neurological disorders. We observed an enhancement in 
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VGAT expression and VGAT-positive presynaptic terminals, which was in line with the 
increase in PV+ interneurons in the hippocampus, in particular in the CA1 region, of young 
KO mice. Of note, the number of PV neurons was slightly decreased in older KO mice. Our 
observation opens therefore the possibility that IL-1 signalling may play a role in the control 
of GABAergic system. Further studies are needed in order to elucidate the involvement of 
this cytokine in the maturation and development of PV+ neurons in the adult mice.  
 
 
Adult IL-1R–/– Mice Display Behavioural Phenotypes Typical of Autism Spectrum 
Disorders 
Autism-spectrum disorders (ASD) and schizophrenia, neurological diseases 
characterized by marked disruptions in information processing and cognition, are 
recognized to result from altered synaptic connectivity and plasticity in the brains of affected 
individuals. They are, in fact, called “synaptopathies”, i.e. “diseases of the synapse”. 
Accordingly, several studies have demonstrated that alterations in the number of synapses 
during development occurs in these pathologies, as shown by the age-dependent analysis 
of dendritic spines, which represent the structural correlate of postsynaptic compartment. 
 
(Modified from: Dendritic spine pathology in neuropsychiatric disorders – Peter Penzes et al., Nature 
Neuroscience 2011) 
 
Indeed, Golgi stained post-mortem ASD human brain tissue revealed an increase in spine 
density on apical dendrites of cortical pyramidal neurons. Of note, spine density was 
inversely correlated with cognitive functions [Penzes P et al., 2011]. These findings are 
consistent with the emerging hypothesis that the brains of individuals with ASD are 
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characterized by hyper connectivity in local circuits and hypoconnectivity between brain 
regions [Geschwind DH and Levitt P, 2007]. Similar to typical autism, the fragile X brain is 
characterized by elevated spine density, with elongated and tortuous spine morphologies, 
indicative of altered function. It is possible that spine dysmorphy contributes to abnormalities 
in specific circuits, which in turn may underlie the behavioural impairments characteristic of 
these disorders [Penzes P et al., 2011].  
We found that IL-1R-/- mice, beside the increased density of dendritic spines demonstrated 
by Golgi staining, display some altered behavioural phenotypes typically found in mouse 
models of ASD. These include an increased self-grooming and alterations of the social 
behaviour. Conversely, no impairments in other cognitive paradigms such as novel object 
recognition task or social novelty test were detected. The established concept that autism 
spectrum disorders is characterized by an increase in spine density [Penzes P et al., 2011], 
imbalance in the ratio between excitation and inhibition [Rubenstein JL and Merzenich MM, 
2003], as well as repetitive behaviours and social defects [Ravizza SM et al., 2013] suggests 
that the lack of IL-1 receptor expression during development leads to behavioural defects 
reminiscent of ASD. It is conceivable that an increase in synaptic connections and a 
consequent alteration of synaptic strength may reshape the neuronal wiring patterns and 
eventually cause atypical brain functions. This possibility is also supported by the results 
from Fang et colleagues, who demonstrated that overproduction of neocortical excitatory 
neurons leads to autism-like features in mice, through the perturbation of dendrites and 
spines formation in excitatory neurons which leads to dysregulated E/I balance. Importantly, 
these mice exhibit behavioural abnormalities resembling those of human autism [Fang WQ 
et al., 2014]. The brain phenotype that we found in IL-1R-/- mice resembles this condition: 
in fact, we demonstrated a significant enhancement of excitatory transmission and an 
increase in spine density in the hippocampus of these mice, with an excitatory/inhibitory 
balance shifted towards excitation in old mice, resulting in defects in behavioural 
phenotypes typical of autism. However, in our mice we did not observe any sign of 
excitotoxicity, and this might be due to the fact that the threshold level of excitatory 
transmission required to trigger neuronal excitotoxic damages and death is not reached.  
 
(Modified from: Overproduction of Upper-Layer Neurons in the 
Neocortex Leads to Autism-like Features in Mice - Wei-Qun Fang et al., Cell Report 2014) 
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In our case, however, we didn’t find any apparent increase in the number of excitatory 
neurons. What could then be the reason of the increase in spine and excitatory synapse 
density detected in IL-1R-/- brain? The first indication came from our observation that the 
excessive excitatory neurotransmission is not detectable in primary cultures of IL-1R-/- 
hippocampal neurons. These data suggested that the genetic lack of IL-1 receptor does not 
induce alterations in synaptic transmission through a neuron-autonomous process, pointing 
instead to a key contribution of non-neuronal cells in driving the process.  
 
 
IL-1 Signaling and Microglia-Mediated Synaptic Pruning 
The most likely candidate to be involved in this process is microglia, the immune 
component present in the brain. One of the most studied function of microglia is their 
significant contribution to synaptic stripping, a process by which microglia monitor synaptic 
function and contribute to synapse stabilization or elimination in the first weeks of postnatal 
life. The process of synaptic pruning is central during brain development, when the excess 
number of synaptic contacts is subsequently eliminated. Correct synaptic pruning is 
necessary for the strengthening of remaining synapses and is critical for normal brain 
development [Riccomagno MM and Kolodkin AL, 2015], leading to short-term effects on 
postnatal synaptic maturation and long-term effects on neural circuit formation. Microglial 
cells play major roles in the process of synaptic pruning, participating in synapse 
remodelling and plasticity [Kettenmann H et al., 2013; Paolicelli RC et al., 2011; Schafer DP 
et al., 2012; Tremblay MÈ et al., 2010]. Microglial phagocytosis relies on cell surface 
receptors, coupled to downstream signaling pathways that control actin remodelling and 
particle engulfment. Previous studies have demonstrated that the microglial engulfment and 
removal of dendritic spines during development occurs via signaling of the neuronal 
chemokine, fractalkine (CX3CL1), to its receptor on microglia (CX3CR1). Using a mouse 
model lacking this receptor, Paolicelli and colleagues observed a significant reduction in 
microglia density, which correlated to a transient deficit in synaptic pruning and circuit 
maturation [Paolicelli et al., 2011] and eventually led to impairments in cognitive function in 
the adult mice [Rogers JT et al., 2011].  
Differently from CX3CR1 KO mice, IL-1R KO mice display a transient increase in 
microglial density at postnatal day 9 in both hippocampus and cortex when compared to 
WT, a difference which was fully recovered in 1-month-old mice. To investigate whether, 
although being more elevated in their number, microglia could be functionally defective, we 
cultured KO microglia with WT neurons and showed that microglia lacking of IL-1 receptor 
prevents the process of synapse elimination in vitro. Our data therefore point to the 
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possibility that, although temporarily increased in their number, microglia from KO mice may 
be defective in the process of synapse elimination even in vivo. The microglia increase in 
vivo might be an event occurring to somehow compensate the deficient microglia-mediated 
synapse pruning. Although we do not provide a direct demonstration that IL-1 receptor 
deficiency in microglia directly contributes to the observed effects on excitatory synapses, 
our results, together with the evidence of reduced synapse elimination when neurons and 
IL-1R-/- microglia are cultured in contact, point to IL-1 signaling being involved in synapse 
phagocytosis, which is consistent with the higher density of pre- and post-synaptic markers 
in the hippocampi of knock-out mice, more abundant dendritic spines and enhanced 
excitatory neurotransmission in acute brain slices.  
As a further evidence pointing to microglia as possible major contributors to the brain 
phenotype found in IL1R KO mice, we observed in these mice defects in a social behaviour 
typical of autism spectrum disorders that has been also demonstrated in Cx3cr1 KO mice, 
further confirming the possibility that a reduced synaptic pruning during development in 
microglia may contribute to circuit-level deficits across neurodevelopmental disorders, 
including autism [Zhan Y et al., 2014].   
Interestingly, ASD development is suggested to involve microglia, through their role in 
synaptic refinement during development. Kim and colleagues showed that deletion of genes 
that are vital for microglial autophagy resulted in social behavioural defects and repetitive 
behaviours [Kim HJ et al., 2017], which recall the IL-1R KO behavioural phenotype. Even 
more interestingly, recent results from our group have demonstrated that defective synaptic 
pruning by microglia lacking the TREM2 receptor results in increased density of excitatory 
terminals and dendritic spines, accompanied by social defects [Filipello F, Morini R et al., 
2018], a phenotype which recapitulates the main features of IL-1R KO mice. However, we 
observed no difference in the microglial expression of this receptor between WT and IL-1R-
/- hippocampi both at 9 and 19 days of age. Since elimination of abnormal synapses during 
development might occur though different pathways, it is possible that the unchanged 
expression of TREM2 in our knock-out microglia does not exclude alterations or impairment 
in other pathways involving the classical complement proteins C1q and C3 among others. 
In fact, we found a strong decrease in the mRNA levels of each C1q subunit in the 
hippocampus of KO mice at P19 if compared to WT controls, suggesting that IL-1R might 
indirectly regulate neuronal C1q expression to initiate complement- and microglia-mediated 
synaptic pruning. 
 
The molecular mechanisms by which IL-1 receptor in microglia may control the 
pruning of supernumerary synapses in the developing brain is still to be defined. We have 
recently reported that in a mouse model of inflammation lacking IL-1R8, a receptor which 
74 | P a g .  
 
dampens the activation of the Toll-like receptor (TLR) and IL-1 receptor signalling pathways, 
the IL-1 signaling is hyperactivated [Tomasoni R et al., 2017]. In this context, we 
demonstrated that the activity of the IL-1 receptor pathway directly affects, in neurons, the 
levels of expression of the methyl-CpG-binding protein 2 (MeCP2), a protein involved in 
neurological diseases (Rett syndrome and MeCP2 duplication syndrome) characterized by 
defective plasticity, impaired cognition and intellectual disability. Our study, by 
demonstrating that hyperactivation of the IL-1 receptor pathway results in the 
overexpression of MeCP2, a synaptic factor that controls spine morphogenesis, synaptic 
transmission and plasticity [Na ES et al., 2013], provides a major breakthrough in the field 
of the cross talk between nervous and immune systems. 
Given the evidence found in IL-1R8 KO mice, characterized by the hyperactivation of IL-1 
pathway, we reasoned that in IL-1R KO mice a decreased expression of MeCP2 could be 
expected. Indeed, western blot analysis of brain homogenates revealed decreased MeCP2 
levels in both cortex and hippocampus of IL-1R deficient mice. Unexpectedly however, 
immunostaining of brain slices for MeCP2 revealed that this decrease was not ascribable 
to pyramidal neurons in the IL-1R-/- hippocampi, but rather to microglial cells. These results 
indicated that a reduction of MeCP2 in neurons is likely not responsible for the augmented 
synaptic transmission and synaptic density observed in the hippocampus of IL-1R KO mice. 
This is also in line with our evidence that the synaptic effects of the genetic lack of IL-1R 
KO do not result from a neuron-autonomous process. Furthermore, they further confirm 
microglia as central player in the observed process. It is known that the transcription factor 
MeCP2 is important for microglial functionality. In fact, MeCP2 regulates microglia and 
macrophage responsiveness to environmental stimuli to promote homeostasis [Cronk JC 
et al., 2015]. MeCP2 expression is also strongly related to regulating the activation states 
of microglia [Jin XR et al., 2017; Zhao D et al., 2017]. Notably, microglia deficient in MeCP2 
show a strong reduction in phagocytic activity, which is important also in synapse stripping. 
Interestingly, the phenotype of MeCP2 knockout mice can be partially rescued by selective 
expression of MeCP2 in cells of the monocytic lineage, including microglia, further 
supporting the central role of this cell type [Derecki NC et al., 2012]. At present there is no 
evidence for a direct correlation between MeCP2 in microglia and synaptic pruning and we 
currently aim to provide this demonstration. The functional analysis of microglia isolated 
from heterozygous MeCP2 mice, which express reduced MeCP2 levels and thus more 
closely reflect the situation we found in IL-1R KO mice, could be advantageous in this 
context.  
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Conclusions and Future Perspectives 
  
We found that IL-1R-/- mice display behavioural defects reminiscent of ASD that are 
associated to an enhanced excitatory neurotransmission and an increased density of 
dendritic spines. Our data suggest that the behavioral defects observed in adult IL-1R 
deficient mice might be due to a deficient microglia-mediated synaptic pruning during 
development rather than to a neuron-autonomous synaptic impairment. To obtain a direct 
demonstration of an impaired microglia-mediated synaptic pruning. We will evaluate the 
levels of synaptic markers in phagocytic organelles of IL-1R-/- microglia in vitro and in vivo. 
The molecular mechanism responsible for these deficits might involve an impaired TGF-β 
secretion by knock-out microglia which, in turn, leads to a downregulated expression of C1q 
proteins and to a dysfunctional elimination of synapses. To assess this hypothesis, we will 
not only quantify secretion of TGF-β from cultured WT and knock-out microglia and its 
effects on C1q expression in vitro by real-time PCR, but we will also evaluate C1q Levels 
in WT and knock-out synaptosomes from brain homogenates by western blotting and WT 
and IL-1R-/- microglia engulfment of synaptosomes from brain tissue by FACS analysis and 
immunostaining.  
It also remains to be determined how the chronic lack of IL-1 receptor in microglia 
results in MeCP2 decrease. IL-1 receptors are known to be expressed on microglia 
(specifically IL-1R1, IL-1R2 and IL-1RAcP [Pinteaux E et al., 2002]). From the literature it is 
known that a transcriptional analysis of purified cultured microglia showed weak expression 
of IL-1RI and stronger expression of IL-1RII, whereas the treatment with LPS significantly 
increased expression of IL-1RI, IL-1RII, and IL-1RacP [Kettenmann H et al., 2011]. Although 
it is now well known that IL-1R signalling in microglia leads to IL-6 and PGE2 release, strong 
activation of ERK1/2, p38 and JNK (p46/p54) and increased NF-κB activity [Pinteaux E et 
al., 2002], the specific role of IL-1 receptor on microglial development and function is not 
completely unravelled. However, it has been observed that the IL-1 type 1 receptor is 
essential for the efficient activation of microglia and the induction of multiple 
proinflammatory mediators in response to brain injury [Basu A et al., 2002]. We have 
previously found that, at least in neurons, the downregulation of MeCP2 expression 
downstream of IL-1R involves PI3 Kinase and mTOR pathways [Tomasoni R et al., 2017]. 
We are currently investigating whether the same pathway is also operating in microglial 
cells. Furthermore, it will be interesting to assess the possibility to recapitulate the observed 
phenotype by administering pharmacological inhibitors of IL-1 receptor (e.g. anakinra) at 
specific developmental stages.  
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